https://childrensoncologygroup.org/publications/feasibility-of-multi-institutional-data-collection-for-medication-prior-authorization-in-pediatric-oncology/2026-08-11T04:02:09+00:00https://childrensoncologygroup.org/publications/intermediate-risk-rhabdomyosarcoma-in-very-young-children-less-than-or-equal-to-24-months-treated-on-the-prior-childrens-oncology-group-protocol-arst1431/2026-08-11T04:02:05+00:00https://childrensoncologygroup.org/publications/new-approaches-to-investigate-novel-agents-in-ewing-sarcoma-a-report-from-the-childrens-oncology-group-bone-tumor-committee/2026-08-11T04:02:08+00:00https://childrensoncologygroup.org/publications/sociodemographics-and-attrition-in-children-with-osteosarcoma-enrolled-in-the-aost0331-clinical-trial/2026-08-11T04:02:05+00:00https://childrensoncologygroup.org/publications/an-efficient-single-arm-bayesian-adaptive-trial-algorithm-to-evaluate-de-intensified-oncologic-treatment/2026-08-11T04:02:07+00:00https://childrensoncologygroup.org/publications/vorinostat-temozolomide-or-bevacizumab-with-irradiation-and-maintenance-bev-tmz-in-pediatric-high-grade-glioma-a-childrens-oncology-group-study/2026-08-11T04:02:20+00:00https://childrensoncologygroup.org/publications/considerations-on-design-and-analysis-of-external-control-in-pediatric-oncology/2026-08-11T04:02:20+00:00https://childrensoncologygroup.org/publications/distinct-hodgkin-lymphoma-subtypes-defined-by-noninvasive-genomic-profiling/2026-08-11T04:02:20+00:00https://childrensoncologygroup.org/publications/a-multi-institutional-feasibility-study-of-intra-arterial-chemotherapy-in-children-with-retinoblastoma-a-childrens-oncology-group-study-cog-aret12p1/2026-08-11T04:02:20+00:00https://childrensoncologygroup.org/publications/late-cardiac-toxic-effects-associated-with-treatment-protocols-for-hodgkin-lymphoma-in-children/2026-08-11T04:02:20+00:00https://childrensoncologygroup.org/publications/outcomes-in-children-adolescents-and-young-adults-with-down-syndrome-and-all-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:20+00:00https://childrensoncologygroup.org/publications/effect-of-carvedilol-versus-placebo-on-cardiac-function-in-anthracycline-exposed-survivors-of-childhood-cancer-prevent-hf-a-randomised-controlled-phase-2b-trial/2026-08-11T04:02:20+00:00https://childrensoncologygroup.org/publications/development-of-osteonecrosis-and-improved-survival-in-b-all-results-of-childrens-oncology-group-trial-aall0232/2026-08-11T04:02:20+00:00https://childrensoncologygroup.org/publications/gaps-in-adolescent-and-young-adult-cancer-education-in-oncology-fellowship-training/2026-08-11T04:02:20+00:00https://childrensoncologygroup.org/publications/utilization-of-teleconsent-for-adolescent-and-young-adult-cancer-clinical-trials-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:20+00:00https://childrensoncologygroup.org/publications/addressing-a-pre-clinical-pipeline-gap-development-of-the-pediatric-acute-myeloid-leukemia-patient-derived-xenograft-program-at-texas-childrens-hospital-at-baylor-college-of-medicine/2026-08-11T04:02:20+00:00https://childrensoncologygroup.org/publications/rna-helicase-ddx3-regulates-rad51-localization-and-dna-damage-repair-in-ewing-sarcoma/2026-08-11T04:02:27+00:00https://childrensoncologygroup.org/publications/reflections-on-the-past-decade-in-evidence-based-practice-within-the-childrens-oncology-group/2026-08-11T04:02:19+00:00https://childrensoncologygroup.org/publications/evidence-based-recommendations-for-education-provided-to-patients-and-families-regarding-the-adverse-events-of-alk-and-mek-inhibitors-a-systematic-review-from-the-childrens-oncology-group/2026-08-11T04:02:19+00:00https://childrensoncologygroup.org/publications/prognostic-impact-of-lymph-node-involvement-and-loss-of-heterozygosity-of-1p-or-16q-in-stage-iii-favorable-histology-wilms-tumor-a-report-from-childrens-oncology-group-studies-aren03b2-and-aren0532/2026-08-11T04:02:19+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-surgery/2026-08-11T04:02:19+00:00https://childrensoncologygroup.org/publications/germline-genetic-testing-and-survival-outcomes-among-children-with-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:19+00:00https://childrensoncologygroup.org/publications/durable-immunity-to-ebv-after-rituximab-and-third-party-lmp-specific-t-cells-a-childrens-oncology-group-study/2026-08-11T04:02:19+00:00https://childrensoncologygroup.org/publications/association-of-the-social-disorganization-index-with-time-to-first-septic-shock-event-in-children-with-acute-myeloid-leukemia/2026-08-11T04:02:19+00:00https://childrensoncologygroup.org/publications/treatment-of-children-with-favorable-histology-wilms-tumor-with-extrapulmonary-metastases-a-report-from-the-cog-studies-aren0533-and-aren03b2-and-nwtsg-study-nwts-5/2026-08-11T04:02:19+00:00https://childrensoncologygroup.org/publications/fertility-preservation-in-pediatric-solid-tumors-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:19+00:00https://childrensoncologygroup.org/publications/enhanced-risk-stratification-for-children-and-young-adults-with-b-cell-acute-lymphoblastic-leukemia-a-childrens-oncology-group-report/2026-08-11T04:02:19+00:00https://childrensoncologygroup.org/publications/dupclinical-practice-guideline-inconsistent-management-of-fever-and-neutropenia-in-pediatric-oncology-a-childrens-oncology-group-study/2026-08-11T04:02:19+00:00https://childrensoncologygroup.org/publications/adolescents-and-young-adults-with-rhabdomyosarcoma-a-report-from-the-soft-tissue-sarcoma-committee-of-the-childrens-oncology-group/2026-08-11T04:02:19+00:00https://childrensoncologygroup.org/publications/race-and-ethnic-group-enrollment-and-outcomes-for-wilms-tumor-analysis-of-the-current-era-childrens-oncology-group-study-aren03b2/2026-08-11T04:02:19+00:00https://childrensoncologygroup.org/publications/personalized-impression-generation-for-pet-reports-using-large-language-models/2026-08-11T04:02:19+00:00https://childrensoncologygroup.org/publications/characteristics-of-health-care-settings-where-adolescents-and-young-adults-receive-care-for-all/2026-08-11T04:02:19+00:00https://childrensoncologygroup.org/publications/chromatin-profiles-are-prognostic-of-clinical-response-to-bortezomib-containing-chemotherapy-in-pediatric-acute-myeloid-leukemia-results-from-the-cog-aaml1031-trial/2026-08-11T04:02:18+00:00https://childrensoncologygroup.org/publications/structural-variants-involving-mllt10-fusion-are-associated-with-adverse-outcomes-in-pediatric-acute-myeloid-leukemia/2026-08-11T04:02:18+00:00https://childrensoncologygroup.org/publications/exosome-mediated-paracrine-signaling-unveils-mir-1246-as-a-driver-of-aggressiveness-in-fusion-negative-rhabdomyosarcoma/2026-08-11T04:02:18+00:00https://childrensoncologygroup.org/publications/rare-germline-structural-variants-increase-risk-for-pediatric-solid-tumors/2026-08-11T04:02:18+00:00https://childrensoncologygroup.org/publications/population-based-data-linkage-describing-patterns-of-cancer-clinical-trial-enrollment-among-children-and-adolescents/2026-08-11T04:02:18+00:00https://childrensoncologygroup.org/publications/accelerating-pediatric-hodgkin-lymphoma-research-the-hodgkin-lymphoma-data-collaboration-nodal/2026-08-11T04:02:18+00:00https://childrensoncologygroup.org/publications/prognostic-impact-of-cooccurring-mutations-in-flt3-itd-pediatric-acute-myeloid-leukemia/2026-08-11T04:02:18+00:00https://childrensoncologygroup.org/publications/mrd-at-the-end-of-induction-and-efs-in-t-cell-lymphoblastic-lymphoma-childrens-oncology-group-trial-aall1231/2026-08-11T04:02:18+00:00https://childrensoncologygroup.org/publications/germ-line-genetic-nbn-variation-and-predisposition-to-b-cell-acute-lymphoblastic-leukemia-in-children/2026-08-11T04:02:18+00:00https://childrensoncologygroup.org/publications/pediatric-and-adolescent-hodgkin-lymphoma-paving-the-way-for-standards-of-care-and-shared-decision-making/2026-08-11T04:02:18+00:00https://childrensoncologygroup.org/publications/phase-ii-study-of-ulixertinib-in-children-and-young-adults-with-tumors-harboring-activating-mitogen-activated-protein-kinase-pathway-alterations-apec1621j-of-the-national-cancer-institute-childrens/2026-08-11T04:02:18+00:00https://childrensoncologygroup.org/publications/artificial-intelligence-based-morphologic-classification-and-molecular-characterization-of-neuroblastic-tumors-from-digital-histopathology/2026-08-11T04:02:18+00:00https://childrensoncologygroup.org/publications/brentuximab-vedotin-and-chemotherapy-in-relapsed-refractory-hodgkin-lymphoma-a-propensity-score-matched-analysis/2026-08-11T04:02:18+00:00https://childrensoncologygroup.org/publications/cardiotoxicity-of-cpx-351-in-children-and-adolescents-with-relapsed-aml-a-childrens-oncology-group-report/2026-08-11T04:02:17+00:00https://childrensoncologygroup.org/publications/ezh2-driven-immune-evasion-defines-high-risk-pediatric-aml-with-t1621-fuserg-gene-fusion/2026-08-11T04:02:17+00:00https://childrensoncologygroup.org/publications/optimized-cytogenetic-risk-group-stratification-of-kmt2a-rearranged-pediatric-acute-myeloid-leukemia/2026-08-11T04:02:17+00:00https://childrensoncologygroup.org/publications/clinical-trial-recruitment-of-people-who-speak-languages-other-than-english-a-childrens-oncology-group-report/2026-08-11T04:02:17+00:00https://childrensoncologygroup.org/publications/treatment-and-outcomes-of-clear-cell-sarcoma-of-the-kidney-a-report-from-the-childrens-oncology-group-studies-aren0321-and-aren03b2/2026-08-11T04:02:17+00:00https://childrensoncologygroup.org/publications/addition-of-temsirolimus-to-chemotherapy-in-children-adolescents-and-young-adults-with-intermediate-risk-rhabdomyosarcoma-arst1431-a-randomised-open-label-phase-3-trial-from-the-childrens-onco/2026-08-11T04:02:17+00:00https://childrensoncologygroup.org/publications/late-cognitive-and-adaptive-outcomes-of-patients-with-neuroblastoma-associated-opsoclonus-myoclonus-ataxia-syndrome-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:17+00:00https://childrensoncologygroup.org/publications/event-free-survival-in-relapsed-and-refractory-rhabdomyosarcoma-treated-on-cooperative-group-phase-ii-trials-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:17+00:00https://childrensoncologygroup.org/publications/bilateral-wilms-tumor-with-anaplasia-a-report-from-the-childrens-oncology-group-study-aren0534/2026-08-11T04:02:17+00:00https://childrensoncologygroup.org/publications/enrollment-on-upfront-high-risk-neuroblastoma-trials-by-race-ethnicity-and-poverty-status-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:17+00:00https://childrensoncologygroup.org/publications/olaparib-for-childhood-tumors-harboring-defects-in-dna-damage-repair-genes-arm-h-of-the-nci-cog-pediatric-match-trial/2026-08-11T04:02:17+00:00https://childrensoncologygroup.org/publications/outcome-of-patients-with-relapsed-or-refractory-nonrhabdomyosarcoma-soft-tissue-sarcomas-enrolled-in-phase-2-cooperative-group-clinical-trials-a-report-from-the-childrens-oncology-group-cancer/2026-08-11T04:02:17+00:00https://childrensoncologygroup.org/publications/impact-of-propofol-exposure-on-neurocognitive-outcomes-in-children-with-high-risk-b-all-a-childrens-oncology-group-study/2026-08-11T04:02:56+00:00https://childrensoncologygroup.org/publications/long-term-follow-up-of-patients-with-intermediate-risk-neuroblastoma-treated-with-response-and-biology-based-therapy-a-report-from-the-childrens-oncology-group-study-anbl0531/2026-08-11T04:02:16+00:00https://childrensoncologygroup.org/publications/clinical-features-and-outcomes-of-young-patients-with-low-grade-non-rhabdomyosarcoma-soft-tissue-sarcomas-treated-with-a-risk-based-strategy-a-report-from-childrens-oncology-group-study-arst0332/2026-08-11T04:02:16+00:00https://childrensoncologygroup.org/publications/integrated-drug-resistance-and-leukemic-stemness-gene-expression-scores-predict-outcomes-in-large-cohort-of-over-3500-aml-patients-from-10-trials/2026-08-11T04:02:16+00:00https://childrensoncologygroup.org/publications/the-genomic-basis-of-childhood-t-lineage-acute-lymphoblastic-leukaemia/2026-08-11T04:02:16+00:00https://childrensoncologygroup.org/publications/embryonal-sarcoma-of-the-liver-in-pediatric-and-young-adult-patients-a-report-from-childrens-oncology-group-study-arst0332/2026-08-11T04:02:17+00:00https://childrensoncologygroup.org/publications/exposure-response-and-subgroup-analyses-to-support-body-weight-based-dosing-of-brentuximab-vedotin-in-children-and-young-adults-with-newly-diagnosed-high-risk-classical-hodgkin-lymphoma/2026-08-11T04:02:17+00:00https://childrensoncologygroup.org/publications/phase-ii-study-of-vemurafenib-in-children-and-young-adults-with-tumors-harboring-braf-v600-mutations-nci-cog-pediatric-match-trial-apec1621-arm-g/2026-08-11T04:02:16+00:00https://childrensoncologygroup.org/publications/impact-of-genetic-ancestry-on-t-cell-acute-lymphoblastic-leukemia-outcomes/2026-08-11T04:02:16+00:00https://childrensoncologygroup.org/publications/identification-of-single-cell-blasts-in-pediatric-acute-myeloid-leukemia-using-an-autoencoder/2026-08-11T04:02:16+00:00https://childrensoncologygroup.org/publications/impact-of-age-on-safety-of-busulfan-melphalan-followed-by-autologous-hematopoietic-stem-cell-transplantation-versus-standard-chemotherapy-in-the-patients-of-the-euro-e-w-i-n-g-99-and-ewing-2008-clini/2026-08-11T04:02:16+00:00https://childrensoncologygroup.org/publications/phase-ii-study-of-samotolisib-in-children-and-young-adults-with-tumors-harboring-phosphoinositide-3-kinase-mammalian-target-of-rapamycin-pathway-alterations-pediatric-match-apec1621d/2026-08-11T04:02:16+00:00https://childrensoncologygroup.org/publications/palbociclib-in-solid-tumor-patients-with-genomic-alterations-in-the-cyclind-cdk4-6-ink4a-rb-pathway-results-from-nci-cog-pediatric-match-trial-arm-i-apec1621i/2026-08-11T04:02:16+00:00https://childrensoncologygroup.org/publications/language-6-mercaptopurine-adherence-and-relapse-in-children-with-acute-lymphoblastic-leukemia/2026-08-11T04:02:16+00:00https://childrensoncologygroup.org/publications/remote-field-application-of-digital-technology-for-hearing-assessments-in-a-cohort-of-pediatric-germ-cell-tumor-survivors/2026-08-11T04:02:16+00:00https://childrensoncologygroup.org/publications/efficacy-of-the-allosteric-mek-inhibitor-trametinib-in-relapsed-and-refractory-juvenile-myelomonocytic-leukemia-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:15+00:00https://childrensoncologygroup.org/publications/carvedilol-to-improve-cardiac-remodeling-in-anthracycline-exposed-childhood-cancer-survivors-subgroup-analysis-of-cog-alte1621/2026-08-11T04:02:15+00:00https://childrensoncologygroup.org/publications/hodgkin-lymphoma-involving-the-extra-axial-cns-an-ahod1331-phl-c1-and-phl-c2-report-from-the-cog-and-euronet-phl/2026-08-11T04:02:15+00:00https://childrensoncologygroup.org/publications/design-and-methods-of-the-stepbystep-randomized-trial-of-a-mobile-health-and-social-media-physical-activity-intervention-among-adolescent-and-young-adult-survivors-of-childhood-cancer-a-report-from-t/2026-08-11T04:02:14+00:00https://childrensoncologygroup.org/publications/a-subset-of-image-defined-risk-factors-predict-completeness-of-resection-in-children-with-high-risk-neuroblastoma-an-international-multicenter-study/2026-08-11T04:02:14+00:00https://childrensoncologygroup.org/publications/clinical-practice-guideline-inconsistent-management-of-fertility-preservation-in-pediatric-cancer-patients-in-community-settings-a-childrens-oncology-group-study/2026-08-11T04:02:15+00:00https://childrensoncologygroup.org/publications/children-and-young-adults-with-newly-diagnosed-rhabdomyosarcoma-metastatic-to-bone-treated-on-childrens-oncology-group-studies/2026-08-11T04:02:15+00:00https://childrensoncologygroup.org/publications/healthcare-utilization-disparities-among-children-with-high-risk-neuroblastoma-treated-on-childrens-oncology-group-clinical-trials/2026-08-11T04:02:15+00:00https://childrensoncologygroup.org/publications/wlongitudinal-health-related-quality-of-life-among-patients-with-high-risk-pediatric-hodgkin-lymphoma-treated-on-the-childrens-oncology-group-ahod-1331-study/2026-08-11T04:02:15+00:00https://childrensoncologygroup.org/publications/cd74-is-expressed-in-a-subset-of-pediatric-acute-myeloid-leukemia-patients-and-is-a-promising-target-for-therapy-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:15+00:00https://childrensoncologygroup.org/publications/improvements-in-childrens-oncology-group-neuroblastoma-risk-stratification-through-a-change-in-age-cut-off-and-use-of-inrgss/2026-08-11T04:02:15+00:00https://childrensoncologygroup.org/publications/braf-exon-15-mutations-in-the-evaluation-of-well-differentiated-epithelial-nephroblastic-neoplasms-in-children/2026-08-11T04:02:15+00:00https://childrensoncologygroup.org/publications/bayesian-semiparametric-model-for-sequential-treatment-decisions-with-informative-timing/2026-08-11T04:02:15+00:00https://childrensoncologygroup.org/publications/automatic-quantification-of-serial-pet-ct-images-for-pediatric-hodgkin-lymphoma-patients-using-a-longitudinally-aware-segmentation-network/2026-08-11T04:02:15+00:00https://childrensoncologygroup.org/publications/poverty-race-ethnicity-and-survival-in-pediatric-nonmetastatic-osteosarcoma-a-childrens-oncology-group-report/2026-08-11T04:02:15+00:00https://childrensoncologygroup.org/publications/impact-of-the-childrens-oncology-groups-supportive-care-clinical-practice-guideline-endorsement-program-an-institutional-survey/2026-08-11T04:02:15+00:00https://childrensoncologygroup.org/publications/sociodemographic-and-socioeconomic-factors-correlate-with-late-stage-pediatric-hodgkin-lymphoma-and-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group-registries/2026-08-11T04:02:14+00:00https://childrensoncologygroup.org/publications/genomic-determinants-of-outcome-in-acute-lymphoblastic-leukemia/2026-08-11T04:02:14+00:00https://childrensoncologygroup.org/publications/fertility-preservation-in-pediatric-central-nervous-system-tumors-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:14+00:00https://childrensoncologygroup.org/publications/attention-and-executive-functioning-in-children-and-adolescents-treated-for-high-risk-acute-lymphoblastic-leukemia-a-report-from-the-childrens-oncology-group-cog/2026-08-11T04:02:14+00:00https://childrensoncologygroup.org/publications/determinants-of-survival-after-first-relapse-of-acute-lymphoblastic-leukemia-a-childrens-oncology-group-study/2026-08-11T04:02:14+00:00https://childrensoncologygroup.org/publications/delivery-of-care-for-pediatric-patients-receiving-blinatumomab-a-childrens-oncology-group-study/2026-08-11T04:02:14+00:00https://childrensoncologygroup.org/publications/outcomes-for-patients-with-perineal-and-perianal-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group-soft-tissue-sarcoma-committee/2026-08-11T04:02:14+00:00https://childrensoncologygroup.org/publications/latest-developments-in-adaptive-enrichment-clinical-trial-designs-in-oncology/2026-08-11T04:02:14+00:00https://childrensoncologygroup.org/publications/multilevel-challenges-to-equitable-inclusion-of-children-in-trials-when-parents-use-languages-other-than-english-a-qualitative-report-from-childrens-oncology-groups-diversity-and-health-disparities/2026-08-11T04:02:14+00:00https://childrensoncologygroup.org/publications/current-practices-for-delivering-new-diagnosis-education-at-childrens-oncology-group-institutions-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:14+00:00https://childrensoncologygroup.org/publications/heterogeneity-of-ikzf1-genomic-alterations-and-risk-of-relapse-in-childhood-b-cell-precursor-acute-lymphoblastic-leukemia/2026-08-11T04:02:14+00:00https://childrensoncologygroup.org/publications/roadmap-for-the-next-generation-of-childrens-oncology-group-rhabdomyosarcoma-trials/2026-08-11T04:02:13+00:00https://childrensoncologygroup.org/publications/long-term-outcomes-and-patterns-of-relapse-in-patients-with-bilateral-wilms-tumor-or-bilaterally-predisposed-unilateral-wilms-tumor-a-report-from-the-cog-aren0534-study/2026-08-11T04:02:13+00:00https://childrensoncologygroup.org/publications/antimetabolite-dose-intensity-and-adverse-outcomes-in-children-with-acute-lymphoblastic-leukemia-a-cog-aall03n1-report/2026-08-11T04:02:13+00:00https://childrensoncologygroup.org/publications/azacitidine-as-epigenetic-priming-for-chemotherapy-is-safe-and-well-tolerated-in-infants-with-newly-diagnosed-kmt2a-rearranged-acute-lymphoblastic-leukemia-childrens-oncology-group-trial-aall15p1/2026-08-11T04:02:13+00:00https://childrensoncologygroup.org/publications/feasibility-of-a-prospective-pediatric-melanocytic-tumor-clinical-trial-a-report-of-multidisciplinary-clinician-survey-data-from-the-childrens-oncology-group-rare-tumor-committee/2026-08-11T04:02:13+00:00https://childrensoncologygroup.org/publications/response-to-induction-chemotherapy-modifies-the-effect-of-conventional-prognostic-factors-in-high-risk-neuroblastoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:13+00:00https://childrensoncologygroup.org/publications/radiation-target-nomenclature-for-lymphoma-trials-consensus-recommendations-from-the-national-clinical-trials-network-groups/2026-08-11T04:02:13+00:00https://childrensoncologygroup.org/publications/long-read-epigenomic-diagnosis-and-prognosis-of-acute-myeloid-leukemia/2026-08-11T04:02:13+00:00https://childrensoncologygroup.org/publications/the-proteomics-of-t-cell-and-early-t-cell-precursor-etp-acute-lymphocytic-leukemia-prognostic-patterns-in-adult-and-pediatric-etp-all-cancers-basel/2026-08-11T04:02:13+00:00https://childrensoncologygroup.org/publications/whole-lung-irradiation-in-rhabdomyosarcoma-with-lung-metastases-a-report-from-the-soft-tissue-sarcoma-committee-of-the-childrens-oncology-group/2026-08-11T04:02:13+00:00https://childrensoncologygroup.org/publications/optimizing-ewing-sarcoma-and-osteosarcoma-biopsy-acquisition-a-childrens-oncology-group-bone-tumor-committee-consensus-statement/2026-08-11T04:02:13+00:00https://childrensoncologygroup.org/publications/a-multiomic-atlas-identifies-a-treatment-resistant-bone-marrow-progenitor-like-cell-population-in-t-cell-acute-lymphoblastic-leukemia/2026-08-11T04:02:12+00:00https://childrensoncologygroup.org/publications/evaluation-of-image-defined-risk-factor-idrf-assessment-in-patients-with-intermediate-risk-neuroblastoma-a-report-from-the-childrens-oncology-group-study-anbl0531/2026-08-11T04:02:12+00:00https://childrensoncologygroup.org/publications/outcomes-of-patients-with-intermediate-risk-neuroblastoma-presenting-with-motor-deficits-relating-to-intraspinal-tumor-extension-a-report-from-the-childrens-oncology-group-study-anbl0531/2026-08-11T04:02:13+00:00https://childrensoncologygroup.org/publications/late-events-occurring-after-5-years-in-pediatric-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group-pediatr-blood-cancer/2026-08-11T04:02:13+00:00https://childrensoncologygroup.org/publications/impact-of-the-covid-19-pandemic-onset-on-the-early-careers-of-pediatric-oncology-health-professionals-and-researchers-a-report-from-the-childrens-oncology-group-young-investigators-committee-young/2026-08-11T04:02:13+00:00https://childrensoncologygroup.org/publications/treatment-of-focal-anaplastic-wilms-tumor-a-report-from-the-childrens-oncology-group-aren0321-and-aren03b2-studies/2026-08-11T04:02:12+00:00https://childrensoncologygroup.org/publications/molecular-characterization-informs-prognosis-in-patients-with-localized-ewing-sarcoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:12+00:00https://childrensoncologygroup.org/publications/racial-and-ethnic-survival-disparities-among-children-with-high-risk-neuroblastoma-a-childrens-oncology-group-report/2026-08-11T04:02:12+00:00https://childrensoncologygroup.org/publications/antileukemia-efficacy-of-the-dual-bcl2-bcl-xl-inhibitor-azd0466-in-acute-lymphoblastic-leukemia-preclinical-models/2026-08-11T04:02:12+00:00https://childrensoncologygroup.org/publications/blinatumomab-in-standard-risk-b-cell-acute-lymphoblastic-leukemia-in-children/2026-08-11T04:02:12+00:00https://childrensoncologygroup.org/publications/otoprotective-effects-of-sodium-thiosulfate-by-demographic-and-clinical-characteristics-a-report-from-childrens-oncology-group-study-accl0431/2026-08-11T04:02:12+00:00https://childrensoncologygroup.org/publications/rhabdoid-tumor-of-the-kidney-and-soft-tissues-results-from-national-wilms-tumor-study-5-and-childrens-oncology-group-study-aren0321/2026-08-11T04:02:12+00:00https://childrensoncologygroup.org/publications/transplant-free-salvage-therapy-for-low-risk-relapsed-pediatric-hodgkin-lymphoma-a-nonrandomized-clinical-trial/2026-08-11T04:02:12+00:00https://childrensoncologygroup.org/publications/clinical-actionability-of-the-nudt15-4-p-r139h-allele-and-its-association-with-hispanic-ethnicity/2026-08-11T04:02:12+00:00https://childrensoncologygroup.org/publications/prevention-and-management-of-infectious-complications-in-pediatric-patients-with-cancer-a-survey-assessment-of-current-practices-across-childrens-oncology-group-institutions/2026-08-11T04:02:12+00:00https://childrensoncologygroup.org/publications/on-the-use-of-external-controls-in-clinical-trials/2026-08-11T04:02:12+00:00https://childrensoncologygroup.org/publications/transplant-free-approach-in-relapsed-hodgkin-lymphoma-in-children-adolescents-and-young-adults-a-nonrandomized-clinical-trial/2026-08-11T04:02:12+00:00https://childrensoncologygroup.org/publications/dna-damage-response-pharmacogenomic-ddr_pgx-score-predicts-response-to-chemotherapy-consisting-of-gemtuzumab-ozogamicin-in-pediatric-aml-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:12+00:00https://childrensoncologygroup.org/publications/isotretinoin-has-no-effect-on-event-free-survival-across-high-risk-medulloblastoma-molecular-groups-when-added-to-maintenance-a-secondary-analysis-of-the-childrens-oncology-group-acns0332/2026-08-11T04:02:12+00:00https://childrensoncologygroup.org/publications/influence-of-nucleophosmin-npm1-genotypes-on-outcome-of-patients-with-aml-an-aieop-bfm-and-cog-swog-intergroup-collaboration/2026-08-11T04:02:11+00:00https://childrensoncologygroup.org/publications/dntt-mediated-dna-damage-response-drives-inotuzumab-ozogamicin-resistance-in-b-cell-acute-lymphoblastic-leukemia-blood/2026-08-11T04:02:11+00:00https://childrensoncologygroup.org/publications/evaluation-and-surgical-management-of-pediatric-cutaneous-melanoma-and-atypical-spitz-and-non-spitz-melanocytic-tumors-melanocytomas-a-report-from-childrens-oncology-group/2026-08-11T04:02:11+00:00https://childrensoncologygroup.org/publications/current-treatment-strategies-and-supportive-care-practices-in-the-care-of-children-and-adolescents-with-mature-b-cell-non-hodgkin-lymphoma-a-survey-of-childrens-oncology-group-institutions/2026-08-11T04:02:11+00:00https://childrensoncologygroup.org/publications/peripheral-t-cell-lymphoma-nos-in-children-and-adolescents-a-review-from-the-childrens-oncology-group-nhl-committee/2026-08-11T04:02:11+00:00https://childrensoncologygroup.org/publications/using-non-inferiority-test-of-proportions-in-design-of-randomized-non-inferiority-trials-with-time-to-event-endpoint-with-a-focus-on-low-event-rate-setting/2026-08-11T04:02:11+00:00https://childrensoncologygroup.org/publications/lymph-node-staging-and-treatment-in-pediatric-patients-with-soft-tissue-sarcomas-a-consensus-opinion-from-the-childrens-oncology-group-european-paediatric-soft-tissue-sarcoma-study-group-and-the-c/2026-08-11T04:02:11+00:00https://childrensoncologygroup.org/publications/likes-and-hashtags-exploring-the-potential-relationship-between-social-media-use-and-the-emotional-wellbeing-of-oncology-professionals/2026-08-11T04:02:11+00:00https://childrensoncologygroup.org/publications/current-surgical-approaches-to-pediatric-renal-tumors/2026-08-11T04:02:11+00:00https://childrensoncologygroup.org/publications/larotrectinib-for-newly-diagnosed-infantile-fibrosarcoma-and-other-pediatric-ntrk-fusion-positive-solid-tumors-childrens-oncology-group-advl1823/2026-08-11T04:02:11+00:00https://childrensoncologygroup.org/publications/protocol-stipulated-dose-modification-to-manage-chemotherapy-induced-peripheral-neuropathy-in-children-adolescents-and-young-adults-with-high-risk-hodgkin-lymphoma/2026-08-11T04:02:11+00:00https://childrensoncologygroup.org/publications/patterns-of-clinical-trial-enrollment-for-pediatric-patients-with-hepatoblastoma-and-wilms-tumor-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:11+00:00https://childrensoncologygroup.org/publications/dna-damage-response-and-repair-genes-and-anthracycline-induced-cardiomyopathy-in-childhood-cancer-survivors-a-report-from-the-childrens-oncology-group-and-the-childhood-cancer-survivor-study/2026-08-11T04:02:11+00:00https://childrensoncologygroup.org/publications/body-composition-at-diagnosis-and-early-response-in-pediatric-hodgkin-lymphoma/2026-08-11T04:02:11+00:00https://childrensoncologygroup.org/publications/associations-of-patient-age-tumor-nephrectomy-weight-and-tumor-diameter-with-event-free-and-overall-survival-in-stage-i-or-ii-favorable-histology-wilms-tumor-a-pooled-analysis-of-childrens-oncolog/2026-08-11T04:02:11+00:00https://childrensoncologygroup.org/publications/hepatosplenic-t-cell-lymphoma-in-children-and-adolescents/2026-08-11T04:02:11+00:00https://childrensoncologygroup.org/publications/guideline-concordant-treatment-among-adolescents-and-young-adults-with-acute-lymphoblastic-leukemia/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/financial-distress-screening-and-navigation-in-pediatric-oncology-within-the-national-cancer-institute-community-oncology-research-program/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/study-of-complementary-and-integrative-interventions-in-pediatric-patients-with-serious-illness/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/automatic-quantification-of-serial-pet-ct-images-for-pediatric-hodgkin-lymphoma-using-a-longitudinally-aware-segmentation-network/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/the-childrens-oncology-group-long-term-follow-up-guidelines-for-survivors-of-childhood-adolescent-and-young-adult-cancers-a-review/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/pet-response-and-outcome-in-low-risk-nodular-lymphocyte-predominant-hodgkin-lymphoma-childrens-oncology-group-study-ahod03p1/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/performance-of-two-phase-designs-for-the-time-to-event-outcome-and-a-case-study-assessing-the-relapse-risk-associated-with-b-all-subtypes/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/phase-i-trial-of-selinexor-in-pediatric-recurrent-refractory-solid-and-cns-tumors-advl1414-a-childrens-oncology-group-phase-i-consortium-trial/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/frequency-and-clinical-significance-of-clonal-and-subclonal-driver-mutations-in-high-risk-neuroblastoma-at-diagnosis-a-childrens-oncology-group-study/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/phase-2-trial-of-veliparib-local-irradiation-and-temozolomide-in-patients-with-newly-diagnosed-high-grade-glioma-a-childrens-oncology-group-study/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/alternative-mrna-splicing-in-anthracycline-induced-cardiomyopathy-a-cog-alte03n1-report-cardiooncology/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/high-immunoproteasome-and-low-constitutive-proteasome-subunit-levels-correlate-with-sensitivity-to-bortezomib-containing-chemotherapy-update-from-the-childrens-oncology-group-aall1231-trial/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/cytarabine-pharmacogenomics-and-outcomes-among-children-and-young-adults-with-acute-myeloid-leukemia/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/evaluation-of-the-childhood-hodgkin-international-prognostic-score-chips-in-high-risk-pediatric-hodgkin-lymphoma-patients-treated-on-childrens-oncology-group-ahod1331/2026-08-11T04:02:09+00:00https://childrensoncologygroup.org/publications/extremity-rhabdomyosarcoma-in-children-adolescents-and-young-adults-a-report-from-childrens-oncology-group-trials/2026-08-11T04:02:09+00:00https://childrensoncologygroup.org/publications/multipotent-lineage-potential-in-b-cell-acute-lymphoblastic-leukemia-is-associated-with-distinct-cellular-origins-and-clinical-features/2026-08-11T04:02:09+00:00https://childrensoncologygroup.org/publications/inferring-chromosome-segregation-error-stage-and-crossover-in-trisomic-disorders-with-application-to-down-syndrome/2026-08-11T04:02:09+00:00https://childrensoncologygroup.org/publications/the-impact-of-genetic-ancestry-on-survival-outcomes-in-pediatric-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:09+00:00https://childrensoncologygroup.org/publications/hematopoietic-stem-cell-transplantation-outcomes-for-high-risk-aml-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:09+00:00https://childrensoncologygroup.org/publications/the-international-soft-tissue-sarcoma-consortium-the-baseline-analysis-of-rhabdomyosarcoma-data/2026-08-11T04:02:09+00:00https://childrensoncologygroup.org/publications/epigenomic-diagnosis-and-prognosis-of-acute-myeloid-leukemia/2026-08-11T04:02:09+00:00https://childrensoncologygroup.org/publications/naprt-expression-and-epigenetic-regulation-in-pediatric-rhabdomyosarcoma-as-a-potential-biomarker-for-nampt-inhibition/2026-08-11T04:02:09+00:00https://childrensoncologygroup.org/publications/clinical-and-pathologic-features-of-535-patients-with-congenital-mesoblastic-nephroma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:09+00:00https://childrensoncologygroup.org/publications/methotrexate-scarcity-among-childrens-oncology-group-institutions-results-of-a-multinational-survey/2026-08-11T04:02:09+00:00https://childrensoncologygroup.org/publications/spatial-and-multi-omic-profiling-reveals-genes-and-pathways-associated-with-cytotoxic-lymphocyte-infiltration-in-malignant-rhabdoid-tumor/2026-08-11T04:02:09+00:00https://childrensoncologygroup.org/publications/incorporation-of-patient-reported-outcomes-in-pediatric-cancer-clinical-trials-design-implementation-and-dissemination/2026-08-11T04:02:08+00:00https://childrensoncologygroup.org/publications/radiation-therapy-dose-escalation-failed-to-improve-local-control-for-intermediate-risk-rhabdomyosarcoma-on-arst1431-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:09+00:00https://childrensoncologygroup.org/publications/impact-of-genetic-ancestry-on-genomics-and-survival-outcomes-in-t-cell-acute-lymphoblastic-leukemia/2026-08-11T04:02:09+00:00https://childrensoncologygroup.org/publications/integrative-and-complementary-interventions-result-in-significant-positive-effect-sizes-in-quality-of-life-and-symptom-burden-among-patients-with-pediatric-cancer-and-other-serious-illness/2026-08-11T04:02:08+00:00https://childrensoncologygroup.org/publications/germline-pathogenic-likely-pathogenic-mutations-and-subsequent-neoplasms-among-childhood-cancer-survivors-a-report-from-the-childrens-oncology-group-alte03n1-study/2026-08-11T04:02:08+00:00https://childrensoncologygroup.org/publications/smarcal1-is-a-new-osteosarcoma-predisposition-gene/2026-08-11T04:02:08+00:00https://childrensoncologygroup.org/publications/group-based-trajectories-of-health-related-quality-of-life-among-pediatric-patients-with-high-risk-hodgkin-lymphoma/2026-08-11T04:02:08+00:00https://childrensoncologygroup.org/publications/germline-cancer-predisposition-results-from-the-national-cancer-institute-childrens-oncology-group-pediatric-match-trial/2026-08-11T04:02:08+00:00https://childrensoncologygroup.org/publications/anthracycline-induced-cardiomyopathy-in-childhood-cancer-survivors-is-associated-with-gene-signatures-of-mitochondrial-dysfunction-a-cog-alte03n1-report/2026-08-11T04:02:08+00:00https://childrensoncologygroup.org/publications/hypothesis-generating-analysis-of-mutational-signatures-in-childhood-b-cell-acute-lymphoblastic-leukemia-in-relation-to-socio-demographic-genetic-and-environmental-factors-a-report-from-the-childre/2026-08-11T04:02:08+00:00https://childrensoncologygroup.org/publications/defining-and-measuring-tolerability-in-pediatric-adolescent-and-young-adult-oncology-the-essential-voices/2026-08-11T04:02:08+00:00https://childrensoncologygroup.org/publications/a-multicenter-observational-cohort-study-in-survivors-of-down-syndrome-associated-acute-leukemia-alte22c1-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:08+00:00https://childrensoncologygroup.org/publications/chromosomal-instability-degrades-developmental-phenotypes-essential-for-anti-gd2-immunotherapy-outcomes-in-high-risk-neuroblastoma/2026-08-11T04:02:08+00:00https://childrensoncologygroup.org/publications/genome-wide-association-study-of-childhood-b-cell-acute-lymphoblastic-leukemia-reveals-novel-african-ancestry-specific-susceptibility-loci/2026-08-11T04:02:08+00:00https://childrensoncologygroup.org/publications/updated-favourable-histology-wilms-tumour-risk-stratification-rationale-for-future-childrens-oncology-group-clinical-trials/2026-08-11T04:02:07+00:00https://childrensoncologygroup.org/publications/histologic-response-to-induction-chemotherapy-in-high-risk-neuroblastoma/2026-08-11T04:02:08+00:00https://childrensoncologygroup.org/publications/financial-distress-screening-and-financial-navigation-among-adolescents-and-young-adults-within-the-national-cancer-institute-community-oncology-research-program-results-of-the-2022-landscape-survey/2026-08-11T04:02:07+00:00https://childrensoncologygroup.org/publications/impact-of-pulmonary-tumor-burden-in-favorable-histology-wilms-tumor-outcomes-a-report-from-the-childrens-oncology-group-study-aren0533/2026-08-11T04:02:07+00:00https://childrensoncologygroup.org/publications/factors-associated-with-primary-site-local-therapy-in-patients-with-nonmetastatic-ewing-sarcoma-treated-with-interval-compressed-chemotherapy-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:05+00:00https://childrensoncologygroup.org/publications/role-of-race-and-ethnicity-in-survival-among-children-young-adults-with-relapsed-all-a-childrens-oncology-group-report/2026-08-11T04:02:07+00:00https://childrensoncologygroup.org/publications/severe-toxicity-and-poor-efficacy-of-reinduction-chemotherapy-are-associated-with-overall-poor-outcomes-in-relapsed-b-cell-acute-lymphoblastic-leukemia-a-report-from-the-childrens-oncology-group-aal/2026-08-11T04:02:07+00:00https://childrensoncologygroup.org/publications/caregivers-perspectives-on-changes-in-family-life-during-b-all-therapy-a-qualitative-study-from-the-childrens-oncology-group/2026-08-11T04:02:07+00:00https://childrensoncologygroup.org/publications/enhancing-prediction-of-cancer-therapy-related-cardiomyopathy-from-surveillance-echocardiograms-a-childrens-oncology-group-study/2026-08-11T04:02:07+00:00https://childrensoncologygroup.org/publications/analysis-of-error-profiles-of-indels-and-structural-variants-in-deep-sequencing-data/2026-08-11T04:02:07+00:00https://childrensoncologygroup.org/publications/malignant-peripheral-nerve-sheath-tumors-a-report-from-childrens-oncology-group-study-arst0332/2026-08-11T04:02:07+00:00https://childrensoncologygroup.org/publications/advancing-preclinical-biology-for-ewing-sarcoma-an-international-effort/2026-08-11T04:02:07+00:00https://childrensoncologygroup.org/publications/sequential-combination-of-unfavorable-histology-followed-by-clinical-stage-m-defines-high-risk-neuroblastoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:06+00:00https://childrensoncologygroup.org/publications/a-phase-2-trial-of-rankl-antibody-denosumab-in-two-cohorts-of-patients-with-recurrent-refractory-osteosarcoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:07+00:00https://childrensoncologygroup.org/publications/age-based-pegaspargase-dosing-is-safe-and-achieves-therapeutic-levels-in-infants-with-all-report-from-cog-aall15p1/2026-08-11T04:02:06+00:00https://childrensoncologygroup.org/publications/tumor-specific-immune-responses-and-biomarkers-in-pediatric-patients-with-high-risk-hodgkin-lymphoma/2026-08-11T04:02:06+00:00https://childrensoncologygroup.org/publications/a-pilot-study-of-chemoimmunotherapy-in-the-postconsolidation-setting-for-high-risk-neuroblastoma-anbl19p1-a-report-from-the-childrens-oncology-group-cancer/2026-08-11T04:02:06+00:00https://childrensoncologygroup.org/publications/evaluating-the-use-of-hierarchical-composite-endpoints-in-pediatric-cancer-supportive-care-clinical-trials-illustrative-examples-from-two-multi-center-phase-iii-randomized-clinical-trials/2026-08-11T04:02:06+00:00https://childrensoncologygroup.org/publications/childhood-cancer-data-initiative-expanded-access-to-tumor-molecular-profiling-for-children-adolescents-and-young-adults/2026-08-11T04:02:06+00:00https://childrensoncologygroup.org/publications/household-poverty-and-obesity-in-children-with-acute-lymphoblastic-leukemia-a-report-from-cog-aall03n1/2026-08-11T04:02:06+00:00https://childrensoncologygroup.org/publications/genome-wide-association-study-meta-analysis-identifies-susceptibility-loci-informing-ewing-sarcoma-etiology-and-potential-mechanisms-of-risk/2026-08-11T04:02:06+00:00https://childrensoncologygroup.org/publications/leveraging-large-language-models-to-extract-prognostic-pathology-features-in-ewing-sarcoma/2026-08-11T04:02:06+00:00https://childrensoncologygroup.org/publications/pediatric-personalized-deep-learning-models-for-segmentation-of-hepatoblastoma-at-ct-and-mri-radiol-imaging-cancer/2026-08-11T04:02:06+00:00https://childrensoncologygroup.org/publications/philadelphia-chromosome-positive-acute-lymphoblastic-leukaemia-in-children-and-adolescents-a-changing-treatment-landscape-and-a-methodological-challenge/2026-08-11T04:02:06+00:00https://childrensoncologygroup.org/publications/collecting-social-determinants-of-health-in-a-childrens-oncology-group-trial-for-high-risk-neuroblastoma/2026-08-11T04:02:05+00:00https://childrensoncologygroup.org/publications/molecular-risk-markers-define-risk-of-relapse-in-myeloid-leukemia-of-down-syndrome-beyond-measurable-residual-disease/2026-08-11T04:02:56+00:00https://childrensoncologygroup.org/publications/single-cell-panleukemia-signatures-of-hspc-like-blasts-predict-drug-response-and-clinical-outcome/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/a-quality-approach-to-blinatumomab-delivery-in-pediatric-oncology-a-childrens-oncology-group-study/2026-08-11T04:02:16+00:00https://childrensoncologygroup.org/publications/topotecan-clearance-based-on-a-single-sample-and-a-population-pharmacokinetic-model-application-to-a-pediatric-high-risk-neuroblastoma-clinical-trial-pediatr-blood-cancer/2026-08-11T04:02:21+00:00https://childrensoncologygroup.org/publications/integrated-genomic-analysis-reveals-aberrations-in-wnt-signaling-in-germ-cell-tumors-of-childhood-and-adolescence/2026-08-11T04:02:30+00:00https://childrensoncologygroup.org/publications/an-analysis-of-major-target-deviations-in-craniospinal-irradiation-treatment-plans-for-patients-with-intermediate-risk-medulloblastoma-within-a-phase-3-clinical-trial-childrens-oncology-group-study/2026-08-11T04:02:32+00:00https://childrensoncologygroup.org/publications/comparison-of-calgb-10403-alliance-and-cog-aall0232-toxicity-results-in-young-adults-with-acute-lymphoblastic-leukemia/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/validation-of-healthcare-professional-proxy-reported-childrens-international-mucositis-evaluation-scale/2026-08-11T04:02:31+00:00https://childrensoncologygroup.org/publications/prevalence-and-clinical-correlations-of-somatostatin-receptor-2-sstr2-expression-in-neuroblastoma/2026-08-11T04:02:55+00:00https://childrensoncologygroup.org/publications/tp53-germline-pathogenic-variant-frequency-in-anaplastic-rhabdomyosarcoma-a-childrens-oncology-group-report/2026-08-11T04:02:30+00:00https://childrensoncologygroup.org/publications/clinical-practice-guideline-recommendation-summaries-for-pediatric-oncology-health-care-professionals-a-qualitative-study/2026-08-11T04:02:31+00:00https://childrensoncologygroup.org/publications/polyclonal-lymphoid-expansion-drives-paraneoplastic-autoimmunity-in-neuroblastoma/2026-08-11T04:02:25+00:00https://childrensoncologygroup.org/publications/six-candidate-mirnas-associated-with-early-relapse-in-pediatric-b-cell-acute-lymphoblastic-leukemia/2026-08-11T04:02:48+00:00https://childrensoncologygroup.org/publications/age-dependency-of-the-prognostic-impact-of-tumor-genomics-in-localized-resectable-mycn-nonamplified-neuroblastomas-report-from-the-siopen-biology-group-on-the-lnesg-trials-and-a-cog-validation-group/2026-08-11T04:02:46+00:00https://childrensoncologygroup.org/publications/adolescent-and-young-adult-aya-versus-pediatric-patients-with-acute-leukemia-have-a-significantly-increased-risk-of-acute-gvhd-following-unrelated-donor-urd-stem-cell-transplantation-sct-the-ch/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/excellent-outcomes-with-reduced-frequency-of-vincristine-and-dexamethasone-pulses-in-standard-risk-b-lymphoblastic-leukemia-results-from-childrens-oncology-group-aall0932/2026-08-11T04:02:42+00:00https://childrensoncologygroup.org/publications/bortezomib-with-standard-chemotherapy-for-children-with-acute-myeloid-leukemia-does-not-improve-treatment-outcomes-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:47+00:00https://childrensoncologygroup.org/publications/current-pediatric-cancer-survivorship-practices-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:25+00:00https://childrensoncologygroup.org/publications/expression-of-neuroblastoma-related-genes-in-bone-marrow-at-end-of-high-risk-neuroblastoma-therapy/2026-08-11T04:02:34+00:00https://childrensoncologygroup.org/publications/management-of-chronic-myeloid-leukemia-in-children-and-adolescents-recommendations-from-the-childrens-oncology-group-cml-working-group/2026-08-11T04:02:53+00:00https://childrensoncologygroup.org/publications/post-traumatic-stress-symptoms-in-adolescent-hodgkin-lymphoma-survivors-a-report-from-childrens-oncology-group-ahod0031/2026-08-11T04:02:27+00:00https://childrensoncologygroup.org/publications/use-of-communication-technology-to-improve-clinical-trial-participation-in-adolescents-and-young-adults-with-cancer-consensus-statement-from-the-childrens-oncology-group-adolescent-and-young-adult-r/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/identified-enrollment-challenges-of-adolescent-and-young-adult-patients-on-the-nonchemotherapy-arm-of-childrens-oncology-group-study-arst1321/2026-08-11T04:02:35+00:00https://childrensoncologygroup.org/publications/do-children-and-adolescents-with-completely-resected-alveolar-rhabdomyosarcoma-require-adjuvant-radiation-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:49+00:00https://childrensoncologygroup.org/publications/suboptimal-outcome-for-patients-with-biliary-rhabdomyosarcoma-treated-on-low-risk-clinical-trials-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:43+00:00https://childrensoncologygroup.org/publications/crizotinib-in-combination-with-chemotherapy-for-pediatric-patients-with-alk-anaplastic-large-cell-lymphoma-the-results-of-childrens-oncology-group-trial-anhl12p1/2026-08-11T04:02:30+00:00https://childrensoncologygroup.org/publications/emerging-novel-agents-for-patients-with-advanced-ewing-sarcoma-a-report-from-the-childrens-oncology-group-cog-new-agents-for-ewing-sarcoma-task-force/2026-08-11T04:02:55+00:00https://childrensoncologygroup.org/publications/risk-associated-alterations-in-marrow-t-cells-in-pediatric-leukemia/2026-08-11T04:02:47+00:00https://childrensoncologygroup.org/publications/the-ganglioside-gd2-as-a-circulating-tumor-biomarker-for-neuroblastoma/2026-08-11T04:02:51+00:00https://childrensoncologygroup.org/publications/association-between-participation-in-clinical-trials-and-overall-survival-among-children-with-intermediate-or-high-risk-neuroblastoma/2026-08-11T04:02:41+00:00https://childrensoncologygroup.org/publications/phase-ii-trial-of-response-based-radiation-therapy-for-patients-with-localized-germinoma-a-childrens-oncology-group-study/2026-08-11T04:02:36+00:00https://childrensoncologygroup.org/publications/cd22low-bcl-2high-expression-identifies-poor-response-to-inotuzumab-ozogamicin-in-relapsed-refractory-acute-lymphoblastic-leukemia/2026-08-11T04:02:32+00:00https://childrensoncologygroup.org/publications/an-evaluation-of-machine-learning-techniques-to-predict-the-outcome-of-children-treated-for-hodgkin-lymphoma-on-the-ahod0031-trial-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:46+00:00https://childrensoncologygroup.org/publications/the-population-pharmacokinetics-of-high-dose-methotrexate-in-infants-with-acute-lymphoblastic-leukemia-highlight-the-need-for-bedside-individualized-dose-adjustment-a-report-from-the-childrens-oncol/2026-08-11T04:02:54+00:00https://childrensoncologygroup.org/publications/comprehensive-molecular-and-clinical-characterization-of-nup98-fusions-in-pediatric-acute-myeloid-leukemia/2026-08-11T04:02:26+00:00https://childrensoncologygroup.org/publications/interest-in-fertility-status-assessment-among-young-adult-survivors-of-childhood-cancer/2026-08-11T04:02:32+00:00https://childrensoncologygroup.org/publications/neoadjuvant-pazopanib-in-nonrhabdomyosarcoma-soft-tissue-sarcomas-arst1321-a-report-of-major-wound-complications-from-the-childrens-oncology-group-and-nrg-oncology/2026-08-11T04:02:30+00:00https://childrensoncologygroup.org/publications/cost-of-survivorship-care-and-adherence-to-screening-aligning-the-priorities-of-health-care-systems-and-survivors/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/inclusion-of-patient-reported-outcomes-in-adolescent-and-young-adult-phase-iii-therapeutic-trials-an-analysis-of-cancer-clinical-trials-registered-on-clinicaltrials-gov/2026-08-11T04:02:39+00:00https://childrensoncologygroup.org/publications/impact-of-diagnostic-and-end-of-induction-curie-scores-with-tandem-high-dose-chemotherapy-and-autologous-transplants-for-metastatic-high-risk-neuroblastoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:26+00:00https://childrensoncologygroup.org/publications/effect-of-a-daily-text-messaging-and-directly-supervised-therapy-intervention-on-oral-mercaptopurine-adherence-in-children-with-acute-lymphoblastic-leukemia-a-randomized-clinical-trial/2026-08-11T04:02:47+00:00https://childrensoncologygroup.org/publications/circulating-tumor-dna-is-prognostic-in-intermediate-risk-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:30+00:00https://childrensoncologygroup.org/publications/imaging-appearance-of-nongerminoma-pediatric-ovarian-germ-cell-tumors-does-not-discriminate-benign-from-malignant-histology/2026-08-11T04:02:42+00:00https://childrensoncologygroup.org/publications/patients-with-completely-resected-nongenitourinary-low-risk-embryonal-rhabdomyosarcoma-are-candidates-for-reduced-duration-low-intensity-chemotherapy/2026-08-11T04:02:32+00:00https://childrensoncologygroup.org/publications/race-disparities-in-proton-radiotherapy-use-for-cancer-treatment-in-patients-enrolled-in-childrens-oncology-group-trials/2026-08-11T04:02:46+00:00https://childrensoncologygroup.org/publications/jak3-mutations-and-mitochondrial-apoptosis-resistance-in-t-cell-acute-lymphoblastic-leukemia/2026-08-11T04:02:36+00:00https://childrensoncologygroup.org/publications/poverty-and-targeted-immunotherapy-survival-in-childrens-oncology-group-clinical-trials-for-high-risk-neuroblastoma/2026-08-11T04:02:43+00:00https://childrensoncologygroup.org/publications/pan-neuroblastoma-analysis-reveals-age-and-signature-associated-driver-alterations/2026-08-11T04:02:46+00:00https://childrensoncologygroup.org/publications/role-of-the-extent-of-prophylactic-regional-lymph-node-radiotherapy-on-survival-in-high-risk-neuroblastoma-a-report-from-the-cog-a3973-study/2026-08-11T04:02:54+00:00https://childrensoncologygroup.org/publications/morphologic-remission-status-is-limited-compared-to-%ce%b4n-flow-cytometry-a-childrens-oncology-group-aaml0531-report/2026-08-11T04:02:46+00:00https://childrensoncologygroup.org/publications/inherited-genetic-susceptibility-to-acute-lymphoblastic-leukemia-in-down-syndrome/2026-08-11T04:02:53+00:00https://childrensoncologygroup.org/publications/an-updated-assessment-of-43110-patients-enrolled-in-the-childhood-cancer-research-network-a-childrens-oncology-group-report/2026-08-11T04:02:35+00:00https://childrensoncologygroup.org/publications/effect-of-postreinduction-therapy-consolidation-with-blinatumomab-vs-chemotherapy-on-disease-free-survival-in-children-adolescents-and-young-adults-with-first-relapse-of-b-cell-acute-lymphoblastic-l/2026-08-11T04:02:43+00:00https://childrensoncologygroup.org/publications/flt3-inhibitor-lestaurtinib-plus-chemotherapy-for-newly-diagnosed-kmt2a-rearranged-infant-acute-lymphoblastic-leukemia-childrens-oncology-group-trial-aall0631/2026-08-11T04:02:42+00:00https://childrensoncologygroup.org/publications/evidence-based-recommendations-for-nurse-monitoring-and-management-of-immunotherapy-induced-cytokine-release-syndrome-a-systematic-review-from-the-childrens-oncology-group/2026-08-11T04:02:39+00:00https://childrensoncologygroup.org/publications/how-to-be-successful-in-an-academic-interview-in-pediatric-oncology-a-survey-of-childrens-oncology-group-cog-and-international-society-of-paediatric-oncology-siop-mentors/2026-08-11T04:02:43+00:00https://childrensoncologygroup.org/publications/clinically-and-biologically-relevant-subgroups-of-wilms-tumour-defined-by-genomic-and-epigenomic-analyses/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/remission-treatment-failure-and-relapse-in-pediatric-all-an-international-consensus-of-the-ponte-di-legno-consortium/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/linking-eortc-qlq-c-30-and-pedsql-pedqol-physical-functioning-scores-in-patients-with-osteosarcoma/2026-08-11T04:02:35+00:00https://childrensoncologygroup.org/publications/durable-remission-for-four-pediatric-patients-with-high-risk-relapsed-classical-hodgkin-lymphoma-treated-with-brentuximab-vedotin-plus-gemcitabine-but-without-autologous-stem-cell-transplantation-a-r/2026-08-11T04:02:36+00:00https://childrensoncologygroup.org/publications/dose-adjusted-etoposide-doxorubicin-and-cyclophosphamide-with-vincristine-and-prednisone-plus-rituximab-therapy-in-children-and-adolescents-with-primary-mediastinal-b-cell-lymphoma-a-multicenter-ph/2026-08-11T04:02:39+00:00https://childrensoncologygroup.org/publications/outcomes-in-adolescent-and-young-adult-patients-16-to-30-years-compared-to-younger-patients-treated-for-high-risk-b-lymphoblastic-leukemia-report-from-childrens-oncology-group-study-aall0232/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/replacing-cyclophosphamide-cytarabine-mercaptopurine-with-cyclophosphamide-etoposide-during-consolidation-delayed-intensification-does-not-improve-outcome-for-pediatric-b-cell-acute-lymphoblastic-leuk/2026-08-11T04:02:55+00:00https://childrensoncologygroup.org/publications/quality-of-life-of-patients-with-osteosarcoma-in-the-european-american-osteosarcoma-study-1-euramos-1-development-and-implementation-of-a-questionnaire-substudy/2026-08-11T04:02:53+00:00https://childrensoncologygroup.org/publications/lymph-node-metastases-in-paediatric-and-young-adult-patients-with-non-rhabdomyosarcoma-soft-tissue-sarcoma-nrsts-findings-from-childrens-oncology-group-cog-study-arst0332/2026-08-11T04:02:32+00:00https://childrensoncologygroup.org/publications/predicting-molecular-subtype-and-survival-of-rhabdomyosarcoma-patients-using-deep-learning-of-he-images-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:32+00:00https://childrensoncologygroup.org/publications/association-of-heterogeneous-mycn-amplification-with-clinical-features-biological-characteristics-and-outcomes-in-neuroblastoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:47+00:00https://childrensoncologygroup.org/publications/masked-hypodiploidy-hypodiploid-acute-lymphoblastic-leukemia-all-mimicking-hyperdiploid-all-in-children-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:53+00:00https://childrensoncologygroup.org/publications/increased-local-failure-for-patients-with-intermediate-risk-rhabdomyosarcoma-on-arst0531-a-report-from-the-childrens-oncology-group-cancer/2026-08-11T04:02:53+00:00https://childrensoncologygroup.org/publications/outstanding-outcomes-with-two-low-intensity-regimens-in-children-with-low-risk-b-all-a-report-from-cog-aall0932/2026-08-11T04:02:27+00:00https://childrensoncologygroup.org/publications/racial-and-ethnic-disparities-in-childhood-and-young-adult-acute-lymphocytic-leukaemia-secondary-analyses-of-eight-childrens-oncology-group-cohort-trials/2026-08-11T04:02:32+00:00https://childrensoncologygroup.org/publications/brentuximab-vedotin-with-chemotherapy-in-pediatric-high-risk-hodgkins-lymphoma/2026-08-11T04:02:33+00:00https://childrensoncologygroup.org/publications/imaging-recommendations-in-pediatric-lymphoma-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:27+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-spine-and-spinal-cord-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-aspnr-white-paper/2026-08-11T04:02:27+00:00https://childrensoncologygroup.org/publications/cd33_pgx6_score-predicts-gemtuzumab-ozogamicin-response-in-childhood-acute-myeloid-leukemia-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:54+00:00https://childrensoncologygroup.org/publications/high-dose-methotrexate-in-pediatric-acute-lymphoblastic-leukemia-predictors-of-delayed-clearance-and-the-effect-of-increased-hydration-rate-on-methotrexate-clearance/2026-08-11T04:02:48+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-abdominal-soft-tissue-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:27+00:00https://childrensoncologygroup.org/publications/fertility-related-worry-among-emerging-adult-cancer-survivors/2026-08-11T04:02:32+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-cardiac-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:27+00:00https://childrensoncologygroup.org/publications/sexual-health-among-adolescent-and-young-adult-cancer-survivors-a-scoping-review-from-the-childrens-oncology-group-adolescent-and-young-adult-oncology-discipline-committee/2026-08-11T04:02:42+00:00https://childrensoncologygroup.org/publications/study-of-unilateral-retinoblastoma-with-and-without-histopathologic-high-risk-features-and-the-role-of-adjuvant-chemotherapy-a-childrens-oncology-group-study/2026-08-11T04:02:52+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-pancreas-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:27+00:00https://childrensoncologygroup.org/publications/outcomes-based-on-histopathologic-response-to-preoperative-chemotherapy-in-children-with-bilateral-wilms-tumor-a-prospective-study-cog-aren0534/2026-08-11T04:02:35+00:00https://childrensoncologygroup.org/publications/acute-erythroid-leukemia-is-enriched-in-nup98-fusions-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:45+00:00https://childrensoncologygroup.org/publications/irf4-translocation-status-in-pediatric-follicular-and-diffuse-large-b-cell-lymphoma-patients-enrolled-in-childrens-oncology-group-trials/2026-08-11T04:02:53+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-testicular-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:28+00:00https://childrensoncologygroup.org/publications/introduction-to-interventional-radiologys-role-in-palliative-care-for-children-with-cancer-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:28+00:00https://childrensoncologygroup.org/publications/late-health-outcomes-after-dexrazoxane-treatment-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/leveraging-clinical-trial-populations-and-data-from-the-childrens-oncology-group-for-cancer-survivorship-research/2026-08-11T04:02:34+00:00https://childrensoncologygroup.org/publications/development-of-a-data-model-and-data-commons-for-germ-cell-tumors/2026-08-11T04:02:48+00:00https://childrensoncologygroup.org/publications/predicted-leukocyte-telomere-length-and-risk-of-germ-cell-tumours/2026-08-11T04:02:35+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-ovarian-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:28+00:00https://childrensoncologygroup.org/publications/outcome-of-patients-with-relapsed-or-progressive-ewing-sarcoma-enrolled-on-cooperative-group-phase-2-clinical-trials-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:39+00:00https://childrensoncologygroup.org/publications/phase-i-ii-study-of-cpx-351-followed-by-fludarabine-cytarabine-and-granulocyte-colony-stimulating-factor-for-children-with-relapsed-acute-myeloid-leukemia-a-report-from-the-childrens-oncology-grou/2026-08-11T04:02:48+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-bone-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:28+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-thyroid-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:28+00:00https://childrensoncologygroup.org/publications/interventions-to-promote-oral-medication-adherence-in-the-pediatric-chronic-illness-population-a-systematic-review-from-the-childrens-oncology-group/2026-08-11T04:02:55+00:00https://childrensoncologygroup.org/publications/clinical-group-and-modified-tnm-stage-for-rhabdomyosarcoma-a-review-from-the-childrens-oncology-group/2026-08-11T04:02:36+00:00https://childrensoncologygroup.org/publications/information-fraction-estimation-based-on-the-number-of-events-within-the-standard-treatment-regimen/2026-08-11T04:02:45+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-extremity-soft-tissue-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:28+00:00https://childrensoncologygroup.org/publications/a-phase-2-trial-of-kir-mismatched-unrelated-donor-transplantation-using-in-vivo-t-cell-depletion-with-antithymocyte-globulin-in-acute-myelogenous-leukemia-childrens-oncology-group-aaml05p1-study/2026-08-11T04:02:49+00:00https://childrensoncologygroup.org/publications/activity-of-vincristine-and-irinotecan-in-diffuse-anaplastic-wilms-tumor-and-therapy-outcomes-of-stage-ii-to-iv-disease-results-of-the-childrens-oncology-group-aren0321-study/2026-08-11T04:02:48+00:00https://childrensoncologygroup.org/publications/treatment-of-stage-i-anaplastic-wilms-tumour-a-report-from-the-childrens-oncology-group-aren0321-study/2026-08-11T04:02:53+00:00https://childrensoncologygroup.org/publications/outcomes-of-paediatric-patients-with-b-cell-acute-lymphocytic-leukaemia-with-abl-class-fusion-in-the-pre-tyrosine-kinase-inhibitor-era-a-multicentre-retrospective-cohort-study/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/efficacy-and-toxicity-of-reduced-vs-standard-dose-pegylated-asparaginase-in-adults-with-philadelphia-chromosome-negative-acute-lymphoblastic-leukemia/2026-08-11T04:02:50+00:00https://childrensoncologygroup.org/publications/outcomes-following-gd2-directed-postconsolidation-therapy-for-neuroblastoma-after-cessation-of-random-assignment-on-anbl0032-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:32+00:00https://childrensoncologygroup.org/publications/utility-of-frozen-section-in-pediatric-and-adolescent-malignant-ovarian-nonseminomatous-germ-cell-tumors-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:34+00:00https://childrensoncologygroup.org/publications/nearly-half-of-tp53-germline-variants-predicted-to-be-pathogenic-in-patients-with-osteosarcoma-are-de-novo-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:46+00:00https://childrensoncologygroup.org/publications/multisystem-inflammatory-syndrome-in-children-and-covid-19-are-distinct-presentations-of-sars-cov-2/2026-08-11T04:02:45+00:00https://childrensoncologygroup.org/publications/comprehensive-serum-proteome-profiling-of-cytokine-release-syndrome-and-immune-effector-cell-associated-neurotoxicity-syndrome-patients-with-b-cell-all-receiving-car-t19/2026-08-11T04:02:34+00:00https://childrensoncologygroup.org/publications/high-dose-chemotherapy-compared-with-standard-chemotherapy-and-lung-radiation-in-ewing-sarcoma-with-pulmonary-metastases-results-of-the-european-ewing-tumour-working-initiative-of-national-groups-99/2026-08-11T04:02:51+00:00https://childrensoncologygroup.org/publications/augmentation-of-therapy-for-combined-loss-of-heterozygosity-1p-and-16q-in-favorable-histology-wilms-tumor-a-childrens-oncology-group-aren0532-and-aren0533-study-report/2026-08-11T04:02:52+00:00https://childrensoncologygroup.org/publications/reduced-morbidity-and-mortality-in-survivors-of-childhood-acute-lymphoblastic-leukemia-a-report-from-the-childhood-cancer-survivor-study/2026-08-11T04:02:46+00:00https://childrensoncologygroup.org/publications/impact-of-the-first-generation-of-childrens-oncology-group-clinical-trials-on-clinical-practice-for-wilms-tumor/2026-08-11T04:02:41+00:00https://childrensoncologygroup.org/publications/patterns-of-translocation-testing-in-patients-enrolling-in-a-cooperative-group-trial-for-newly-diagnosed-metastatic-ewing-sarcoma/2026-08-11T04:02:39+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-adrenal-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:28+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-calvarial-and-skull-base-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-aspnr-white-paper-pediatr-blood-cancer/2026-08-11T04:02:28+00:00https://childrensoncologygroup.org/publications/evidence-based-recommendations-for-the-appropriate-level-of-sedation-to-manage-pain-in-pediatric-oncology-patients-requiring-procedures-a-systematic-review-from-the-childrens-oncology-group/2026-08-11T04:02:51+00:00https://childrensoncologygroup.org/publications/implementing-and-evaluating-a-standardized-new-diagnosis-education-checklist-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:42+00:00https://childrensoncologygroup.org/publications/intensive-multimodality-therapy-for-extraocular-retinoblastoma-a-childrens-oncology-group-trial-aret0321/2026-08-11T04:02:33+00:00https://childrensoncologygroup.org/publications/childrens-oncology-group-aall0434-a-phase-iii-randomized-clinical-trial-testing-nelarabine-in-newly-diagnosed-t-cell-acute-lymphoblastic-leukemia/2026-08-11T04:02:46+00:00https://childrensoncologygroup.org/publications/a-randomized-trial-of-caspofungin-vs-triazoles-prophylaxis-for-invasive-fungal-disease-in-pediatric-allogeneic-hematopoietic-cell-transplant/2026-08-11T04:02:43+00:00https://childrensoncologygroup.org/publications/phase-ii-study-of-selumetinib-in-children-and-young-adults-with-tumors-harboring-activating-mitogen-activated-protein-kinase-pathway-genetic-alterations-arm-e-of-the-nci-cog-pediatric-match-trial/2026-08-11T04:02:35+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-neuroblastoma-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:28+00:00https://childrensoncologygroup.org/publications/results-of-treatment-for-patients-with-multicentric-or-bilaterally-predisposed-unilateral-wilms-tumor-aren0534-a-report-from-the-childrens-oncology-group-cancer/2026-08-11T04:02:47+00:00https://childrensoncologygroup.org/publications/kidney-preservation-and-wilms-tumor-development-in-children-with-diffuse-hyperplastic-perilobar-nephroblastomatosis-a-report-from-the-childrens-oncology-group-study-aren0534/2026-08-11T04:02:36+00:00https://childrensoncologygroup.org/publications/importance-of-central-imaging-review-in-a-pediatric-hodgkin-lymphoma-trial-using-positron-emission-tomography-response-adapted-radiation-therapy/2026-08-11T04:02:26+00:00https://childrensoncologygroup.org/publications/long-noncoding-rna-expression-independently-predicts-outcome-in-pediatric-acute-myeloid-leukemia/2026-08-11T04:02:28+00:00https://childrensoncologygroup.org/publications/improving-infectious-adverse-event-reporting-for-children-and-adolescents-enrolled-in-clinical-trials-for-acute-lymphoblastic-leukemia-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:33+00:00https://childrensoncologygroup.org/publications/outcomes-of-intensification-of-induction-chemotherapy-for-children-with-high-risk-acute-myeloid-leukemia-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:39+00:00https://childrensoncologygroup.org/publications/analysis-of-local-control-outcomes-and-clinical-prognostic-factors-in-localized-pelvic-ewing-sarcoma-patients-treated-with-radiation-therapy-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:32+00:00https://childrensoncologygroup.org/publications/polygenic-ara-c-response-score-identifies-pediatric-patients-with-acute-myeloid-leukemia-in-need-of-chemotherapy-augmentation/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/fertility-preservation-practices-at-pediatric-oncology-institutions-in-the-united-states-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:31+00:00https://childrensoncologygroup.org/publications/alveolar-rhabdomyosarcoma-has-superior-response-rates-to-vinorelbine-compared-to-embryonal-rhabdomyosarcoma-in-patients-with-relapsed-refractory-disease-a-meta-analysis/2026-08-11T04:02:30+00:00https://childrensoncologygroup.org/publications/mentors-perspectives-on-the-successes-and-challenges-of-mentoring-in-the-cog-young-investigator-mentorship-program-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:53+00:00https://childrensoncologygroup.org/publications/toward-systematic-assessment-and-improvement-of-radiation-therapy-plan-quality-of-cooperative-group-trial-submissions-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:26+00:00https://childrensoncologygroup.org/publications/impact-of-genomic-and-clinical-factors-on-outcome-of-children-%e2%89%a518-months-of-age-with-stage-3-neuroblastoma-with-unfavorable-histology-and-without-mycn-amplification-a-childrens-oncology-grou/2026-08-11T04:02:30+00:00https://childrensoncologygroup.org/publications/haptoglobin-gene-expression-and-anthracycline-related-cardiomyopathy-in-childhood-cancer-survivors-a-cog-alte03n1-report/2026-08-11T04:02:28+00:00https://childrensoncologygroup.org/publications/creation-of-a-quality-improvement-collaborative-to-address-adolescent-and-young-adult-cancer-clinical-trial-enrollment-ataqi-aya-trial-access-quality-initiative/2026-08-11T04:02:21+00:00https://childrensoncologygroup.org/publications/higher-reported-lung-dose-received-during-total-body-irradiation-for-allogeneic-hematopoietic-stem-cell-transplantation-in-children-with-acute-lymphoblastic-leukemia-is-associated-with-inferior-surviv/2026-08-11T04:02:54+00:00https://childrensoncologygroup.org/publications/impaired-neurocognitive-functioning-3-months-following-diagnosis-of-high-risk-acute-lymphoblastic-leukemia-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:26+00:00https://childrensoncologygroup.org/publications/phase-ii-trial-of-response-based-radiation-therapy-for-patients-with-localized-cns-nongerminomatous-germ-cell-tumors-a-childrens-oncology-group-study/2026-08-11T04:02:51+00:00https://childrensoncologygroup.org/publications/kmt2a-partner-genes-in-infant-acute-lymphoblastic-leukemia-have-prognostic-significance-and-correlate-with-age-white-blood-cell-count-sex-and-central-nervous-system-involvement-a-childrens-oncolo/2026-08-11T04:02:22+00:00https://childrensoncologygroup.org/publications/assessment-of-enrollment-characteristics-for-childrens-oncology-group-cog-upfront-therapeutic-clinical-trials-2004-2015-plos-one/2026-08-11T04:02:49+00:00https://childrensoncologygroup.org/publications/phase-ii-randomized-trial-of-lenalidomide-in-children-with-pilocytic-astrocytomas-and-optic-pathway-gliomas-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:27+00:00https://childrensoncologygroup.org/publications/prospective-evaluation-of-galactomannan-and-1%e2%86%923-%ce%b2-d-glucan-assays-as-diagnostic-tools-for-invasive-fungal-disease-in-children-adolescents-and-young-adults-with-acute-myeloid-leukemia/2026-08-11T04:02:40+00:00https://childrensoncologygroup.org/publications/effect-of-caspofungin-vs-fluconazole-prophylaxis-on-invasive-fungal-disease-among-children-and-young-adults-with-acute-myeloid-leukemia-a-randomized-clinical-trial/2026-08-11T04:02:52+00:00https://childrensoncologygroup.org/publications/prospective-evaluation-of-the-fungitell-1%e2%86%923-beta-d-glucan-assay-as-a-diagnostic-tool-for-invasive-fungal-disease-in-pediatric-allogeneic-hematopoietic-cell-transplantation-a-repo/2026-08-11T04:02:32+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-head-and-neck-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-aspnr-white-paper/2026-08-11T04:02:28+00:00https://childrensoncologygroup.org/publications/excellent-outcomes-in-children-and-adolescents-with-cns-burkitt-lymphoma-or-other-mature-b-nhl-using-only-intrathecal-and-systemic-chemoimmunotherapy-results-from-fab-lmb96-and-cog-anhl01p1/2026-08-11T04:02:55+00:00https://childrensoncologygroup.org/publications/pediatric-oncology-clinician-communication-about-sexual-health-with-adolescents-and-young-adults-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:41+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-brain-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-aspnr-white-paper/2026-08-11T04:02:28+00:00https://childrensoncologygroup.org/publications/infrastructure-of-fertility-preservation-services-for-pediatric-cancer-patients-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-hematopoietic-stem-cell-transplant-recipients-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:28+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-renal-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper-focused-on-wilms-tumor-and-nephrogenic-rests/2026-08-11T04:02:28+00:00https://childrensoncologygroup.org/publications/cost-utility-of-early-breast-cancer-surveillance-in-survivors-of-thoracic-radiation-treated-adolescent-hodgkin-lymphoma/2026-08-11T04:02:51+00:00https://childrensoncologygroup.org/publications/genetic-changes-associated-with-relapse-in-favorable-histology-wilms-tumor-a-childrens-oncology-group-aren03b2-study/2026-08-11T04:02:35+00:00https://childrensoncologygroup.org/publications/alveolar-rhabdomyosarcoma-with-regional-nodal-involvement-results-of-a-combined-analysis-from-two-cooperative-groups/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/the-effects-of-pazopanib-on-doxorubicin-pharmacokinetics-in-children-and-adults-with-non-rhabdomyosarcoma-soft-tissue-sarcoma-a-report-from-childrens-oncology-group-and-nrg-oncology-study-arst1321/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/a-ten-gene-dna-damage-response-pathway-gene-expression-signature-predicts-gemtuzumab-ozogamicin-response-in-pediatric-aml-patients-treated-on-cogaaml0531-and-aaml03p1-trials/2026-08-11T04:02:34+00:00https://childrensoncologygroup.org/publications/a-prospective-study-of-pediatric-and-adolescent-renal-cell-carcinoma-a-report-from-the-childrens-oncology-group-aren0321-study/2026-08-11T04:02:45+00:00https://childrensoncologygroup.org/publications/introduction-to-interventional-oncology-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:28+00:00https://childrensoncologygroup.org/publications/advl1522-a-phase-2-study-of-lorvotuzumab-mertansine-imgn901-in-children-with-relapsed-or-refractory-wilms-tumor-rhabdomyosarcoma-neuroblastoma-pleuropulmonary-blastoma-malignant-peripheral-nerv/2026-08-11T04:02:45+00:00https://childrensoncologygroup.org/publications/adolescent-and-young-adult-oral-maxillofacial-tumors-a-single-institution-case-series-and-literature-review/2026-08-11T04:02:49+00:00https://childrensoncologygroup.org/publications/cytarabine-dose-reduction-in-patients-with-low-risk-acute-myeloid-leukemia-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/effect-of-dexrazoxane-on-left-ventricular-systolic-function-and-treatment-outcomes-in-patients-with-acute-myeloid-leukemia-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:48+00:00https://childrensoncologygroup.org/publications/body-mass-index-associated-with-childhood-and-adolescent-high-risk-b-cell-acute-lymphoblastic-leukemia-risk-a-childrens-oncology-group-report/2026-08-11T04:02:46+00:00https://childrensoncologygroup.org/publications/gene-level-analysis-of-anthracycline-induced-cardiomyopathy-in-cancer-survivors-a-report-from-cog-alte03n1-bmtss-and-ccss/2026-08-11T04:02:21+00:00https://childrensoncologygroup.org/publications/germline-predisposition-to-pediatric-ewing-sarcoma-is-characterized-by-inherited-pathogenic-variants-in-dna-damage-repair-genes/2026-08-11T04:02:36+00:00https://childrensoncologygroup.org/publications/subsequent-malignant-neoplasms-among-children-with-hodgkin-lymphoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/central-nervous-system-status-is-prognostic-in-t-cell-acute-lymphoblastic-leukemia-a-childrens-oncology-group-report/2026-08-11T04:02:30+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-pulmonary-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:29+00:00https://childrensoncologygroup.org/publications/myeloablative-busulfan-melphalan-consolidation-following-induction-chemotherapy-for-patients-with-newly-diagnosed-high-risk-neuroblastoma-childrens-oncology-group-trial-anbl12p1/2026-08-11T04:02:42+00:00https://childrensoncologygroup.org/publications/outstanding-outcomes-in-infants-with-kmt2a-germline-acute-lymphoblastic-leukemia-treated-with-chemotherapy-alone-results-of-the-childrens-oncology-group-aall0631-trial/2026-08-11T04:02:36+00:00https://childrensoncologygroup.org/publications/immune-function-in-childhood-cancer-survivors-a-childrens-oncology-group-review-lancet-child-adolesc-health/2026-08-11T04:02:43+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-extragonadal-pelvic-soft-tissue-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:29+00:00https://childrensoncologygroup.org/publications/sex-based-disparities-in-outcome-in-pediatric-acute-lymphoblastic-leukemia-a-childrens-oncology-group-report/2026-08-11T04:02:36+00:00https://childrensoncologygroup.org/publications/impact-of-asparaginase-discontinuation-on-outcome-in-childhood-acute-lymphoblastic-leukemia-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:48+00:00https://childrensoncologygroup.org/publications/adolescent-young-adult-perspectives-of-a-therapeutic-music-video-intervention-to-improve-resilience-during-hematopoietic-stem-cell-transplant-for-cancer/2026-08-11T04:02:50+00:00https://childrensoncologygroup.org/publications/randomized-clinical-trial-of-a-self-care-and-communication-intervention-for-parents-of-adolescent-young-adults-undergoing-high-risk-cancer-treatment-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:35+00:00https://childrensoncologygroup.org/publications/an-update-on-rhabdomyosarcoma-risk-stratification-and-the-rationale-for-current-and-future-childrens-oncology-group-clinical-trials/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/genome-wide-association-study-identifies-robo2-as-a-novel-susceptibility-gene-for-anthracycline-related-cardiomyopathy-in-childhood-cancer-survivors/2026-08-11T04:02:31+00:00https://childrensoncologygroup.org/publications/metabolic-response-as-assessed-by-18-f-fluorodeoxyglucose-positron-emission-tomography-computed-tomography-does-not-predict-outcome-in-patients-with-intermediate-or-high-risk-rhabdomyosarcoma-a-re/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/late-isolated-central-nervous-system-relapse-in-childhood-b-cell-acute-lymphoblastic-leukemia-treated-with-intensified-systemic-therapy-and-delayed-reduced-dose-cranial-radiation-a-report-from-the-ch/2026-08-11T04:02:39+00:00https://childrensoncologygroup.org/publications/prognostic-significance-of-etp-phenotype-and-minimal-residual-disease-in-t-all-a-childrens-oncology-group-study/2026-08-11T04:02:21+00:00https://childrensoncologygroup.org/publications/sars-cov-2-infections-in-patients-enrolled-on-the-childrens-oncology-group-standard-risk-b-cell-acute-lymphoblastic-leukemia-trial-aall1731/2026-08-11T04:02:26+00:00https://childrensoncologygroup.org/publications/successful-outcomes-of-newly-diagnosed-t-lymphoblastic-lymphoma-results-from-childrens-oncology-group-aall0434/2026-08-11T04:02:46+00:00https://childrensoncologygroup.org/publications/survival-outcomes-of-patients-with-localized-foxo1-fusion-positive-rhabdomyosarcoma-treated-on-recent-clinical-trials-a-report-from-the-soft-tissue-sarcoma-committee-of-the-childrens-oncology-group/2026-08-11T04:02:43+00:00https://childrensoncologygroup.org/publications/effect-of-rituximab-on-immune-status-in-children-with-mature-b-cell-non-hodgkin-lymphoma-a-prespecified-secondary-analysis-of-the-inter-b-nhl-ritux-2010-trial/2026-08-11T04:02:29+00:00https://childrensoncologygroup.org/publications/refinement-of-risk-stratification-for-childhood-rhabdomyosarcoma-using-foxo1-fusion-status-in-addition-to-established-clinical-outcome-predictors-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:53+00:00https://childrensoncologygroup.org/publications/transcriptome-analysis-of-desmoplastic-small-round-cell-tumors-identifies-actionable-therapeutic-targets-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:47+00:00https://childrensoncologygroup.org/publications/phase-2-study-of-anti-disialoganglioside-antibody-dinutuximab-in-combination-with-gm-csf-in-patients-with-recurrent-osteosarcoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:34+00:00https://childrensoncologygroup.org/publications/high-dose-arac-is-essential-for-the-treatment-of-ml-ds-independent-of-postinduction-mrd-results-of-the-cog-aaml1531-trial/2026-08-11T04:02:39+00:00https://childrensoncologygroup.org/publications/childrens-oncology-group-aall1331-phase-iii-trial-of-blinatumomab-in-children-adolescents-and-young-adults-with-low-risk-b-cell-all-in-first-relapse/2026-08-11T04:02:23+00:00https://childrensoncologygroup.org/publications/randomized-phase-iii-trial-of-ganitumab-with-interval-compressed-chemotherapy-for-patients-with-newly-diagnosed-metastatic-ewing-sarcoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:30+00:00https://childrensoncologygroup.org/publications/clinical-relevance-of-proteomic-profiling-in-de-novo-pediatric-acute-myeloid-leukemia-a-childrens-oncology-group-study/2026-08-11T04:02:33+00:00https://childrensoncologygroup.org/publications/heat-shock-factor-1-hsf1-pser326-predicts-response-to-bortezomib-containing-chemotherapy-in-pediatric-aml-a-cog-report/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/loss-to-follow-up-of-minorities-adolescents-and-young-adults-on-clinical-trials-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:30+00:00https://childrensoncologygroup.org/publications/improving-the-pediatric-patient-experience-during-radiation-therapy-a-childrens-oncology-group-study/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/rhabdomyosarcoma-with-isolated-lung-metastases-a-report-from-the-soft-tissue-sarcoma-committee-of-the-childrens-oncology-group/2026-08-11T04:02:29+00:00https://childrensoncologygroup.org/publications/individual-prediction-of-nonadherence-to-oral-mercaptopurine-in-children-with-acute-lymphoblastic-leukemia-results-from-cog-aall03n1/2026-08-11T04:02:40+00:00https://childrensoncologygroup.org/publications/the-effects-of-sample-handling-on-proteomics-assessed-by-reverse-phase-protein-arrays-rppa-functional-proteomic-profiling-in-leukemia/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/bortezomib-reinduction-chemotherapy-in-high-risk-all-in-first-relapse-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:54+00:00https://childrensoncologygroup.org/publications/advances-in-radiotherapy-technology-for-pediatric-cancer-patients-and-roles-of-medical-physicists-cog-and-siop-europe-perspectives/2026-08-11T04:02:42+00:00https://childrensoncologygroup.org/publications/practice-patterns-and-recommendations-for-pediatric-image-guided-radiotherapy-a-childrens-oncology-group-report/2026-08-11T04:02:46+00:00https://childrensoncologygroup.org/publications/integrated-stem-cell-signature-and-cytomolecular-risk-determination-in-pediatric-acute-myeloid-leukemia/2026-08-11T04:02:33+00:00https://childrensoncologygroup.org/publications/cbfb-myh11-fusion-transcripts-distinguish-acute-myeloid-leukemias-with-distinct-molecular-landscapes-and-outcomes/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/dexrazoxane-and-long-term-heart-function-in-survivors-of-childhood-cancer/2026-08-11T04:02:30+00:00https://childrensoncologygroup.org/publications/long-term-follow-up-care-for-childhood-adolescent-and-young-adult-cancer-survivors/2026-08-11T04:02:40+00:00https://childrensoncologygroup.org/publications/subgrouping-of-unfavorable-histology-neuroblastomas-with-immunohistochemistry-toward-precision-prognosis-and-therapy-stratification/2026-08-11T04:02:54+00:00https://childrensoncologygroup.org/publications/survival-of-patients-with-neuroblastoma-after-assignment-to-reduced-therapy-because-of-the-12-to-18-month-change-in-age-cutoff-in-childrens-oncology-group-risk-stratification/2026-08-11T04:02:27+00:00https://childrensoncologygroup.org/publications/revised-neuroblastoma-risk-classification-system-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:40+00:00https://childrensoncologygroup.org/publications/adaptive-functioning-and-academic-achievement-in-survivors-of-childhood-acute-lymphoblastic-leukemia-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:43+00:00https://childrensoncologygroup.org/publications/mri-features-of-histologically-diagnosed-supratentorial-primitive-neuroectodermal-tumors-and-pineoblastomas-in-correlation-with-molecular-diagnoses-and-outcomes-a-report-from-the-childrens-oncology/2026-08-11T04:02:52+00:00https://childrensoncologygroup.org/publications/comparison-of-the-different-imaging-modalities-used-to-image-pediatric-oncology-patients-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:29+00:00https://childrensoncologygroup.org/publications/reducing-adolescent-and-young-adult-cancer-outcome-disparities-through-optimized-care-delivery-a-blueprint-from-the-childrens-oncology-group/2026-08-11T04:02:29+00:00https://childrensoncologygroup.org/publications/inefficiency-of-two-stage-designs-in-phase-ii-oncology-clinical-trials-with-high-proportion-of-inevaluable-patients-contemp-clin-trials/2026-08-11T04:02:34+00:00https://childrensoncologygroup.org/publications/a-gene-expression-based-model-predicts-outcome-in-children-with-intermediate-risk-classical-hodgkin-lymphoma/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/a-single-arm-study-of-systemic-and-sub-tenon-chemotherapy-for-groups-c-and-d-intraocular-retinoblastoma-a-childrens-oncology-group-study-aret-0231/2026-08-11T04:02:47+00:00https://childrensoncologygroup.org/publications/mesothelin-is-a-novel-cell-surface-disease-marker-and-potential-therapeutic-target-in-acute-myeloid-leukemia/2026-08-11T04:02:42+00:00https://childrensoncologygroup.org/publications/survival-by-race-and-ethnicity-in-pediatric-and-adolescent-patients-with-hodgkin-lymphoma-a-childrens-oncology-group-study/2026-08-11T04:02:52+00:00https://childrensoncologygroup.org/publications/survival-by-age-in-paediatric-and-adolescent-patients-with-hodgkin-lymphoma-a-retrospective-pooled-analysis-of-childrens-oncology-group-trials/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/impact-of-race-and-ethnicity-on-presentation-and-outcomes-of-patients-treated-on-rhabdomyosarcoma-clinical-trials-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:29+00:00https://childrensoncologygroup.org/publications/minimal-adjuvant-chemotherapy-for-children-with-hepatoblastoma-resected-at-diagnosis-ahep0731-a-childrens-oncology-group-multicentre-phase-3-trial/2026-08-11T04:02:55+00:00https://childrensoncologygroup.org/publications/doxorubicin-in-combination-with-cisplatin-5-flourouracil-and-vincristine-is-feasible-and-effective-in-unresectable-hepatoblastoma-a-childrens-oncology-group-study/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/stage-4s-neuroblastoma-molecular-histologic-and-immunohistochemical-characteristics-and-presence-of-2-distinct-patterns-of-mycn-protein-overexpression-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:41+00:00https://childrensoncologygroup.org/publications/transition-practices-for-survivors-of-childhood-cancer-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:31+00:00https://childrensoncologygroup.org/publications/response-adapted-therapy-for-the-treatment-of-children-with-newly-diagnosed-high-risk-hodgkin-lymphoma-ahod0831-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:53+00:00https://childrensoncologygroup.org/publications/cancer-informatics-for-cancer-centers-scientific-drivers-for-informatics-data-science-and-care-in-pediatric-adolescent-and-young-adult-cancer/2026-08-11T04:02:41+00:00https://childrensoncologygroup.org/publications/pathogenic-germline-variants-in-cancer-susceptibility-genes-in-children-and-young-adults-with-rhabdomyosarcoma/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/point-and-interval-estimation-in-two-stage-adaptive-designs-with-time-to-event-data-and-biomarker-driven-subpopulation-selection/2026-08-11T04:02:47+00:00https://childrensoncologygroup.org/publications/samhd1-single-nucleotide-polymorphisms-impact-outcome-in-children-with-newly-diagnosed-acute-myeloid-leukemia/2026-08-11T04:02:27+00:00https://childrensoncologygroup.org/publications/survey-of-paediatric-oncologists-and-pathologists-regarding-their-views-and-experiences-with-variant-translocations-in-ewing-and-ewing-like-sarcoma-a-report-of-the-childrens-oncology-group-sarcoma/2026-08-11T04:02:45+00:00https://childrensoncologygroup.org/publications/characterizing-lymphovascular-invasion-in-pediatric-and-adolescent-malignant-ovarian-nongerminomatous-germ-cell-tumors-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:21+00:00https://childrensoncologygroup.org/publications/characterization-of-unusual-iamp21-b-lymphoblastic-leukemia-iamp21-all-from-the-mayo-clinic-and-childrens-oncology-group/2026-08-11T04:02:33+00:00https://childrensoncologygroup.org/publications/phase-ii-trial-of-the-glycoprotein-non-metastatic-b-targeted-antibody-drug-conjugate-glembatumumab-vedotin-cdx-011-in-recurrent-osteosarcoma-aost1521-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:52+00:00https://childrensoncologygroup.org/publications/effects-of-dexrazoxane-on-doxorubicin-related-cardiotoxicity-and-second-malignant-neoplasms-in-children-with-osteosarcoma-a-report-from-the-childrens-oncology-group-cardiooncology/2026-08-11T04:02:52+00:00https://childrensoncologygroup.org/publications/assessment-of-arsenic-trioxide-and-all-trans-retinoic-acid-for-the-treatment-of-pediatric-acute-promyelocytic-leukemia-a-report-from-the-childrens-oncology-group-aaml1331-trial/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/phase-ii-study-of-nonmetastatic-desmoplastic-medulloblastoma-in-children-younger-than-4-years-of-age-a-report-of-the-childrens-oncology-group-acns1221/2026-08-11T04:02:50+00:00https://childrensoncologygroup.org/publications/management-and-outcomes-of-chest-wall-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group-soft-tissue-sarcoma-committee/2026-08-11T04:02:26+00:00https://childrensoncologygroup.org/publications/cd123-expression-is-associated-with-high-risk-disease-characteristics-in-childhood-acute-myeloid-leukemia-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/survival-of-patients-with-orbital-and-eyelid-rhabdomyosarcoma-treated-on-childrens-oncology-group-studies-from-1997-to-2013-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:29+00:00https://childrensoncologygroup.org/publications/obesity-in-children-with-acute-promyelocytic-leukemia-what-is-its-prevalence-and-prognostic-significance/2026-08-11T04:02:36+00:00https://childrensoncologygroup.org/publications/benefit-of-delayed-primary-excision-in-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group-cancer/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/relationship-between-tumor-response-at-therapy-completion-and-prognosis-in-patients-with-group-iii-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:47+00:00https://childrensoncologygroup.org/publications/vincristine-irinotecan-temsirolimus-upfront-window-treatment-of-high-risk-hepatoblastoma-a-report-from-the-childrens-oncology-group-ahep0731-study-committee/2026-08-11T04:02:27+00:00https://childrensoncologygroup.org/publications/prognostic-value-of-chest-x-ray-and-ct-defined-large-mediastinal-adenopathy-in-high-risk-pediatric-hodgkin-lymphoma-a-report-from-the-childrens-oncology-group-study-ahod0831/2026-08-11T04:02:26+00:00https://childrensoncologygroup.org/publications/efficacy-of-carboplatin-and-isotretinoin-in-children-with-high-risk-medulloblastoma-a-randomized-clinical-trial-from-the-childrens-oncology-group/2026-08-11T04:02:40+00:00https://childrensoncologygroup.org/publications/phase-iii-trial-adding-vincristine-topotecan-cyclophosphamide-to-the-initial-treatment-of-patients-with-nonmetastatic-ewing-sarcoma-a-childrens-oncology-group-report/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/association-of-genetic-ancestry-with-the-molecular-subtypes-and-prognosis-of-childhood-acute-lymphoblastic-leukemia/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/genome-wide-association-study-of-susceptibility-loci-for-tcf3-pbx1-acute-lymphoblastic-leukemia-in-children/2026-08-11T04:02:41+00:00https://childrensoncologygroup.org/publications/severe-hepatopathy-in-national-wilms-tumor-studies-3-5-prevalence-clinical-features-and-outcomes-after-reintroduction-of-chemotherapy/2026-08-11T04:02:23+00:00https://childrensoncologygroup.org/publications/temozolomide-with-irinotecan-versus-temozolomide-irinotecan-plus-bevacizumab-for-recurrent-medulloblastoma-of-childhood-report-of-a-cog-randomized-phase-ii-screening-trial/2026-08-11T04:02:41+00:00https://childrensoncologygroup.org/publications/outcomes-after-late-bone-marrow-and-very-early-central-nervous-system-relapse-of-childhood-b-acute-lymphoblastic-leukemia-a-report-from-the-childrens-oncology-group-phase-iii-study-aall0433/2026-08-11T04:02:45+00:00https://childrensoncologygroup.org/publications/germline-cancer-predisposition-variants-in-pediatric-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:41+00:00https://childrensoncologygroup.org/publications/germline-runx1-variation-and-predisposition-to-childhood-acute-lymphoblastic-leukemia/2026-08-11T04:02:42+00:00https://childrensoncologygroup.org/publications/tailoring-therapy-for-children-with-neuroblastoma-on-the-basis-of-risk-group-classification-past-present-and-future/2026-08-11T04:02:46+00:00https://childrensoncologygroup.org/publications/cardiometabolic-risk-in-childhood-cancer-survivors-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/the-use-of-interval-compressed-chemotherapy-with-the-addition-of-vincristine-irinotecan-and-temozolomide-for-pediatric-patients-with-newly-diagnosed-desmoplastic-small-round-cell-tumor/2026-08-11T04:02:46+00:00https://childrensoncologygroup.org/publications/prospective-evaluation-of-radiation-dose-escalation-in-patients-with-high-risk-neuroblastoma-and-gross-residual-disease-after-surgery-a-report-from-the-childrens-oncology-group-anbl0532-study/2026-08-11T04:02:47+00:00https://childrensoncologygroup.org/publications/bayesian-adaptive-trial-design-for-a-continuous-biomarker-with-possibly-nonlinear-or-nonmonotone-prognostic-or-predictive-effects/2026-08-11T04:02:33+00:00https://childrensoncologygroup.org/publications/valosin-containing-protein-vcp-p97-is-prognostically-unfavorable-in-pediatric-aml-and-negatively-correlates-with-unfolded-protein-response-proteins-ire1-and-grp78-a-report-from-the-childrens-onco/2026-08-11T04:02:21+00:00https://childrensoncologygroup.org/publications/pathologic-cytogenetic-and-molecular-features-of-acute-myeloid-leukemia-with-megakaryocytic-differentiation-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:30+00:00https://childrensoncologygroup.org/publications/growth-hormone-deficiency-in-childhood-intracranial-germ-cell-tumor-survivors/2026-08-11T04:02:36+00:00https://childrensoncologygroup.org/publications/recent-advances-in-pediatric-bladder-malignancies/2026-08-11T04:02:50+00:00https://childrensoncologygroup.org/publications/brentuximab-vedotin-in-combination-with-chemotherapy-for-pediatric-patients-with-alk-alcl-results-of-cog-trial-anhl12p1/2026-08-11T04:02:41+00:00https://childrensoncologygroup.org/publications/kir-kir-ligand-genotypes-and-clinical-outcomes-following-chemoimmunotherapy-in-patients-with-relapsed-or-refractory-neuroblastoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:32+00:00https://childrensoncologygroup.org/publications/germline-genetic-variants-and-pediatric-rhabdomyosarcoma-outcomes-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:27+00:00https://childrensoncologygroup.org/publications/circulating-tumor-dna-as-a-biomarker-in-patients-with-stage-iii-and-iv-wilms-tumor-analysis-from-a-childrens-oncology-group-trial-aren0533/2026-08-11T04:02:34+00:00https://childrensoncologygroup.org/publications/evaluating-disparities-in-proton-radiation-therapy-use-in-ahod1331-a-contemporary-childrens-oncology-group-trial-for-advanced-stage-hodgkin-lymphoma/2026-08-11T04:02:39+00:00https://childrensoncologygroup.org/publications/radiation-therapy-use-in-refractory-and-relapsed-adolescent-and-young-adult-hodgkin-lymphoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:22+00:00https://childrensoncologygroup.org/publications/photon-versus-proton-whole-ventricular-radiotherapy-for-non-germinomatous-germ-cell-tumors-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:34+00:00https://childrensoncologygroup.org/publications/outcome-in-children-with-standard-risk-b-cell-acute-lymphoblastic-leukemia-results-of-childrens-oncology-group-trial-aall0331/2026-08-11T04:02:50+00:00https://childrensoncologygroup.org/publications/baseline-metabolic-tumour-burden-improves-risk-stratification-in-hodgkin-lymphoma-a-childrens-oncology-group-study/2026-08-11T04:02:29+00:00https://childrensoncologygroup.org/publications/reevaluation-of-sodium-thiosulfate-otoprotection-using-the-consensus-international-society-of-paediatric-oncology-ototoxicity-scale-a-report-from-the-childrens-oncology-group-study-accl0431/2026-08-11T04:02:26+00:00https://childrensoncologygroup.org/publications/joint-adult-and-pediatric-working-group-as-a-successful-platform-to-strengthen-adolescent-and-young-adult-aya-clinical-trial-collaboration-a-report-from-the-nctn-sarc-aya-clinical-trials-sarcoma-wo/2026-08-11T04:02:22+00:00https://childrensoncologygroup.org/publications/randomized-phase-ii-trial-of-bevacizumab-or-temsirolimus-in-combination-with-chemotherapy-for-first-relapse-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:52+00:00https://childrensoncologygroup.org/publications/risk-based-treatment-for-patients-with-first-relapse-or-progression-of-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:53+00:00https://childrensoncologygroup.org/publications/pathologic-features-of-down-syndrome-myelodysplastic-syndrome-and-acute-myeloid-leukemia-a-report-from-the-childrens-oncology-group-protocol-aaml0431/2026-08-11T04:02:49+00:00https://childrensoncologygroup.org/publications/excellent-long-term-survival-of-children-with-down-syndrome-and-standard-risk-all-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:54+00:00https://childrensoncologygroup.org/publications/favorable-trisomies-and-etv6-runx1-predict-cure-in-low-risk-b-cell-acute-lymphoblastic-leukemia-results-from-childrens-oncology-group-trial-aall0331/2026-08-11T04:02:42+00:00https://childrensoncologygroup.org/publications/predicting-response-to-chemotherapy-in-patients-with-newly-diagnosed-high-risk-neuroblastoma-a-report-from-the-international-neuroblastoma-risk-group/2026-08-11T04:02:39+00:00https://childrensoncologygroup.org/publications/neuroblastoma-in-relation-to-joint-effects-of-vitamin-a-and-maternal-and-offspring-variants-in-vitamin-a-related-genes-a-report-of-the-childrens-oncology-group/2026-08-11T04:02:54+00:00https://childrensoncologygroup.org/publications/magnetic-resonance-and-computed-tomography-imaging-features-of-epithelioid-sarcoma-in-children-and-young-adults-with-pathological-and-clinical-correlation-a-report-from-childrens-oncology-group-stud/2026-08-11T04:02:54+00:00https://childrensoncologygroup.org/publications/factors-affecting-adolescents-willingness-to-communicate-symptoms-during-cancer-treatment-a-systematic-review-from-the-childrens-oncology-group/2026-08-11T04:02:55+00:00https://childrensoncologygroup.org/publications/fertility-preservation-in-pediatric-leukemia-and-lymphoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:26+00:00https://childrensoncologygroup.org/publications/outcomes-after-preoperative-chemoradiation-with-or-without-pazopanib-in-non-rhabdomyosarcoma-soft-tissue-sarcoma-a-report-from-childrens-oncology-group-and-nrg-oncology/2026-08-11T04:02:22+00:00https://childrensoncologygroup.org/publications/poverty-and-relapse-risk-in-children-with-acute-lymphoblastic-leukemia-a-childrens-oncology-group-study-aall03n1-report/2026-08-11T04:02:26+00:00https://childrensoncologygroup.org/publications/glucocorticoids-paradoxically-facilitate-steroid-resistance-in-t-cell-acute-lymphoblastic-leukemias-and-thymocytes/2026-08-11T04:02:50+00:00https://childrensoncologygroup.org/publications/altered-peripheral-blood-gene-expression-in-childhood-cancer-survivors-with-anthracycline-induced-cardiomyopathy-a-cog-alte03n1-report/2026-08-11T04:02:22+00:00https://childrensoncologygroup.org/publications/childrens-oncology-group-phase-iii-trial-of-reduced-dose-and-reduced-volume-radiotherapy-with-chemotherapy-for-newly-diagnosed-average-risk-medulloblastoma/2026-08-11T04:02:41+00:00https://childrensoncologygroup.org/publications/childrens-oncology-group-kidscare-smartphone-application-for-parents-of-children-with-cancer/2026-08-11T04:02:29+00:00https://childrensoncologygroup.org/publications/prognostic-value-of-baseline-metabolic-tumor-volume-in-children-and-adolescents-with-intermediate-risk-hodgkin-lymphoma-treated-with-chemo-radiation-therapy-fdg-pet-parameter-analysis-in-a-subgroup-f/2026-08-11T04:02:40+00:00https://childrensoncologygroup.org/publications/long-term-outcomes-in-patients-with-localized-ewing-sarcoma-treated-with-interval-compressed-chemotherapy-on-childrens-oncology-group-study-aews0031/2026-08-11T04:02:22+00:00https://childrensoncologygroup.org/publications/rates-of-laboratory-adverse-events-by-course-in-paediatric-leukaemia-ascertained-with-automated-electronic-health-record-extraction-a-retrospective-cohort-study-from-the-childrens-oncology-group/2026-08-11T04:02:34+00:00https://childrensoncologygroup.org/publications/automated-ascertainment-of-typhlitis-from-the-electronic-health-record/2026-08-11T04:02:34+00:00https://childrensoncologygroup.org/publications/challenges-and-barriers-to-adverse-event-reporting-in-clinical-trials-a-childrens-oncology-group-report/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/local-control-for-high-grade-nonrhabdomyosarcoma-soft-tissue-sarcoma-assigned-to-radiation-therapy-on-arst0332-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:41+00:00https://childrensoncologygroup.org/publications/rituximab-for-high-risk-mature-b-cell-non-hodgkins-lymphoma-in-children/2026-08-11T04:02:48+00:00https://childrensoncologygroup.org/publications/barriers-to-pediatric-oncologist-enrollment-of-adolescents-and-young-adults-on-a-cross-network-national-clinical-trials-network-supportive-care-cancer-clinical-trial/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/shared-barriers-and-facilitators-to-enrollment-of-adolescents-and-young-adults-on-cancer-clinical-trials/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/irinotecan-temozolomide-and-dinutuximab-with-gm-csf-in-children-with-refractory-or-relapsed-neuroblastoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:48+00:00https://childrensoncologygroup.org/publications/lag-3-is-expressed-on-a-majority-of-tumor-infiltrating-lymphocytes-in-pediatric-hodgkin-lymphoma/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/feasibility-of-combining-temsirolimus-to-vincristine-dactinomycin-cyclophosphamide-and-vincristine-and-irinotecan-chemotherapy-for-children-with-intermediate-risk-rhabdomyosarcoma-a-report-from-ch/2026-08-11T04:02:29+00:00https://childrensoncologygroup.org/publications/comprehensive-characterization-of-pharmacogenetic-variants-in-tpmt-and-nudt15-in-children-with-acute-lymphoblastic-leukemia/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/bilateral-breast-masses-as-a-presentation-for-t-cell-acute-lymphoblastic-leukaemia/2026-08-11T04:02:47+00:00https://childrensoncologygroup.org/publications/a-phase-ii-study-of-alisertib-in-children-with-recurrent-refractory-solid-tumors-or-leukemia-childrens-oncology-group-phase-i-and-pilot-consortium-advl0921/2026-08-11T04:02:54+00:00https://childrensoncologygroup.org/publications/prognostic-impact-of-pretreatment-immunoglobulin-clonal-composition-in-pediatric-b-lymphoblastic-leukemia/2026-08-11T04:02:31+00:00https://childrensoncologygroup.org/publications/tazemetostat-for-tumors-harboring-smarcb1-smarca4-or-ezh2-alterations-results-from-nci-cog-pediatric-match-apec1621c/2026-08-11T04:02:21+00:00https://childrensoncologygroup.org/publications/identification-of-novel-hypermethylated-or-hypomethylated-cpg-sites-and-genes-associated-with-anthracycline-induced-cardiomyopathy/2026-08-11T04:02:25+00:00https://childrensoncologygroup.org/publications/development-of-acute-lymphoblastic-leukemia-following-treatment-for-acute-myeloid-leukemia-in-children-with-down-syndrome-a-case-report-and-retrospective-review-of-childrens-oncology-group-acute-mye/2026-08-11T04:02:54+00:00https://childrensoncologygroup.org/publications/a-phase-2-trial-of-response-based-radiation-therapy-for-localized-central-nervous-system-germ-cell-tumors-patterns-of-failure-and-radiation-dosimetry-for-nongerminomatous-germ-cell-tumors/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/quality-of-life-in-pediatric-acute-myeloid-leukemia-report-from-the-childrens-oncology-group/2026-08-11T04:02:54+00:00https://childrensoncologygroup.org/publications/aberrantly-low-stat3-and-stat5-responses-are-associated-with-poor-outcome-and-an-inflammatory-gene-expression-signature-in-pediatric-acute-myeloid-leukemia/2026-08-11T04:02:40+00:00https://childrensoncologygroup.org/publications/new-approaches-to-risk-stratification-for-wilms-tumor/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/the-clinical-and-biological-characteristics-of-nup98-kdm5a-in-pediatric-acute-myeloid-leukemia/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/minimal-residual-disease-predicts-outcomes-in-kmt2a-rearranged-but-not-kmt2a-germline-infant-acute-lymphoblastic-leukemia-report-from-childrens-oncology-group-study-aall0631/2026-08-11T04:02:29+00:00https://childrensoncologygroup.org/publications/reverse-phase-protein-array-profiling-identifies-recurrent-protein-expression-patterns-of-dna-damage-related-proteins-across-acute-and-chronic-leukemia-samples-from-adults-and-the-childrens-oncology/2026-08-11T04:02:31+00:00https://childrensoncologygroup.org/publications/phase-ii-trial-of-inotuzumab-ozogamicin-in-children-and-adolescents-with-relapsed-or-refractory-b-cell-acute-lymphoblastic-leukemia-childrens-oncology-group-protocol-aall1621/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/the-genetic-and-epigenetic-features-of-bilateral-wilms-tumor-predisposition-a-report-from-the-childrens-oncology-group-aren18b5-q-study/2026-08-11T04:02:31+00:00https://childrensoncologygroup.org/publications/dna-damage-response-related-proteins-are-prognostic-for-outcome-in-both-adult-and-pediatric-acute-myelogenous-leukemia-patients-samples-from-adults-and-from-children-enrolled-in-a-childrens-oncology/2026-08-11T04:02:31+00:00https://childrensoncologygroup.org/publications/mixed-phenotype-acute-leukemia-a-cohort-and-consensus-research-strategy-from-the-childrens-oncology-group-acute-leukemia-of-ambiguous-lineage-task-force/2026-08-11T04:02:50+00:00https://childrensoncologygroup.org/publications/assessment-of-provider-perspectives-on-otoprotection-research-for-children-and-adolescents-a-childrens-oncology-group-cancer-control-and-supportive-care-committee-survey/2026-08-11T04:02:46+00:00https://childrensoncologygroup.org/publications/prognosis-of-children-and-young-adults-with-newly-diagnosed-rhabdomyosarcoma-metastatic-to-bone-marrow-treated-on-childrens-oncology-group-studies/2026-08-11T04:02:21+00:00https://childrensoncologygroup.org/publications/sodium-thiosulfate-for-prevention-of-cisplatin-induced-hearing-loss-updated-survival-from-accl0431/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/prohibitin-is-a-prognostic-marker-and-therapeutic-target-to-block-chemotherapy-resistance-in-wilms-tumor/2026-08-11T04:02:53+00:00https://childrensoncologygroup.org/publications/performance-of-the-fact-gog-ntx-to-assess-chemotherapy-induced-peripheral-neuropathy-cipn-in-pediatric-high-risk-hodgkin-lymphoma-report-from-the-childrens-oncology-group-ahod-1331-study/2026-08-11T04:02:21+00:00https://childrensoncologygroup.org/publications/mutational-and-functional-genetics-mapping-of-chemotherapy-resistance-mechanisms-in-relapsed-acute-lymphoblastic-leukemia/2026-08-11T04:02:46+00:00https://childrensoncologygroup.org/publications/assessment-of-proxy-reported-responses-as-predictors-of-motor-and-sensory-peripheral-neuropathy-in-children-with-b-lymphoblastic-leukemia/2026-08-11T04:02:22+00:00https://childrensoncologygroup.org/publications/introduction-to-the-cog-diagnostic-imaging-committee-spr-oncology-committee-white-papers-rationale-and-methods/2026-08-11T04:02:29+00:00https://childrensoncologygroup.org/publications/osteosarcoma-explorer-a-data-commons-with-clinical-genomic-protein-and-tissue-imaging-data-for-osteosarcoma-research/2026-08-11T04:02:23+00:00https://childrensoncologygroup.org/publications/prioritization-of-novel-agents-for-patients-with-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group-cog-new-agents-for-rhabdomyosarcoma-task-force/2026-08-11T04:02:43+00:00https://childrensoncologygroup.org/publications/ccgg-deletion-rs201074739-in-cd33-results-in-premature-termination-codon-and-complete-loss-of-cd33-expression-another-key-variant-with-potential-impact-on-response-to-cd33-directed-agents/2026-08-11T04:02:53+00:00https://childrensoncologygroup.org/publications/deciphering-the-significance-of-cd56-expression-in-pediatric-acute-myeloid-leukemia-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:51+00:00https://childrensoncologygroup.org/publications/targeted-radiotherapy-for-early-stage-low-risk-pediatric-hodgkin-lymphoma-slow-early-responders-a-cog-ahod0431-analysis/2026-08-11T04:02:34+00:00https://childrensoncologygroup.org/publications/patterns-of-initial-relapse-from-a-phase-3-study-of-response-based-therapy-for-high-risk-hodgkin-lymphoma-ahod0831-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/effect-of-tandem-autologous-stem-cell-transplant-vs-single-transplant-on-event-free-survival-in-patients-with-high-risk-neuroblastoma-a-randomized-clinical-trial/2026-08-11T04:02:53+00:00https://childrensoncologygroup.org/publications/actionable-tumor-alterations-and-treatment-protocol-enrollment-of-pediatric-and-young-adult-patients-with-refractory-cancers-in-the-national-cancer-institute-childrens-oncology-group-pediatric-match/2026-08-11T04:02:35+00:00https://childrensoncologygroup.org/publications/outcome-analysis-of-stage-i-epithelial-predominant-favorable-histology-wilms-tumors-a-report-from-childrens-oncology-group-study-aren03b2/2026-08-11T04:02:48+00:00https://childrensoncologygroup.org/publications/rare-tumors-opportunities-and-challenges-from-the-childrens-oncology-group-perspective/2026-08-11T04:02:21+00:00https://childrensoncologygroup.org/publications/rationale-and-design-of-the-childrens-oncology-group-study-aaml1831-integrated-cardiac-substudies-in-pediatric-acute-myeloid-leukemia-therapy/2026-08-11T04:02:21+00:00https://childrensoncologygroup.org/publications/a-review-of-chronic-leukoencephalopathy-among-survivors-of-childhood-cancer/2026-08-11T04:02:51+00:00https://childrensoncologygroup.org/publications/genomic-variants-of-cytarabine-sensitivity-associated-with-treatment-related-mortality-in-pediatric-aml-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:48+00:00https://childrensoncologygroup.org/publications/the-nsd2-p-e1099k-mutation-is-enriched-at-relapse-and-confers-drug-resistance-in-a-cell-context-dependent-manner-in-pediatric-acute-lymphoblastic-leukemia/2026-08-11T04:02:47+00:00https://childrensoncologygroup.org/publications/measurable-residual-disease-and-fusion-partner-independently-predict-survival-and-relapse-risk-in-childhood-kmt2a-rearranged-acute-myeloid-leukemia-a-study-by-the-international-berlin-frankfurt-munst/2026-08-11T04:02:29+00:00https://childrensoncologygroup.org/publications/predictors-of-differential-response-to-induction-therapy-in-high-risk-neuroblastoma-a-report-from-the-childrens-oncology-group-cog/2026-08-11T04:02:55+00:00https://childrensoncologygroup.org/publications/pharmacogenomic-associations-of-cyclophosphamide-pharmacokinetic-candidate-genes-with-event-free-survival-in-intermediate-risk-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:39+00:00https://childrensoncologygroup.org/publications/sorafenib-in-combination-with-standard-chemotherapy-for-children-with-high-allelic-ratio-flt3-itd-acute-myeloid-leukemia-a-report-from-the-childrens-oncology-group-protocol-aaml1031/2026-08-11T04:02:35+00:00https://childrensoncologygroup.org/publications/gemtuzumab-ozogamicin-improves-event-free-survival-and-reduces-relapse-in-pediatric-kmt2a-rearranged-aml-results-from-the-phase-iii-childrens-oncology-group-trial-aaml0531/2026-08-11T04:02:40+00:00https://childrensoncologygroup.org/publications/blood-count-recovery-following-induction-therapy-for-acute-myeloid-leukemia-in-children-does-not-predict-survival/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/fanconi-brca-pathway-mutations-in-childhood-t-cell-acute-lymphoblastic-leukemia/2026-08-11T04:02:52+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-radiation-oncology/2026-08-11T04:02:23+00:00https://childrensoncologygroup.org/publications/genome-wide-association-study-of-susceptibility-loci-for-t-cell-acute-lymphoblastic-leukemia-in-children/2026-08-11T04:02:51+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-myeloid-neoplasms/2026-08-11T04:02:23+00:00https://childrensoncologygroup.org/publications/impact-of-corticosteroid-pretreatment-in-pediatric-patients-with-newly-diagnosed-b-lymphoblastic-leukemia-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:52+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-central-nervous-system-tumors/2026-08-11T04:02:23+00:00https://childrensoncologygroup.org/publications/abcb1-snp-predicts-outcome-in-patients-with-acute-myeloid-leukemia-treated-with-gemtuzumab-ozogamicin-a-report-from-childrens-oncology-group-aaml0531-trial/2026-08-11T04:02:54+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-hodgkin-lymphoma/2026-08-11T04:02:23+00:00https://childrensoncologygroup.org/publications/letting-kids-be-kids-a-quality-improvement-project-to-deliver-supportive-care-at-home-after-high-dose-methotrexate-in-pediatric-patients-with-acute-lymphoblastic-leukemia/2026-08-11T04:02:49+00:00https://childrensoncologygroup.org/publications/attendance-at-national-cancer-institute-and-childrens-oncology-group-facilities-for-children-adolescents-and-young-adults-with-cancer-in-pennsylvania-a-population-based-study/2026-08-11T04:02:50+00:00https://childrensoncologygroup.org/publications/survival-following-relapse-in-children-with-acute-myeloid-leukemia-a-report-from-aml-bfm-and-cog/2026-08-11T04:02:42+00:00https://childrensoncologygroup.org/publications/practice-patterns-of-pediatric-total-body-irradiation-techniques-a-childrens-oncology-group-survey/2026-08-11T04:02:39+00:00https://childrensoncologygroup.org/publications/prognostic-impact-of-minimal-residual-disease-at-the-end-of-consolidation-in-nci-standard-risk-b-lymphoblastic-leukemia-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:43+00:00https://childrensoncologygroup.org/publications/efficacy-of-high-dose-chemotherapy-and-three-dimensional-conformal-radiation-for-atypical-teratoid-rhabdoid-tumor-a-report-from-the-childrens-oncology-group-trial-acns0333/2026-08-11T04:02:49+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-diversity-and-health-disparities/2026-08-11T04:02:23+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-bone-tumors/2026-08-11T04:02:23+00:00https://childrensoncologygroup.org/publications/trial-design-challenges-and-approaches-for-precision-oncology-in-rare-tumors-experiences-of-the-childrens-oncology-group/2026-08-11T04:02:52+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-liver-tumors/2026-08-11T04:02:24+00:00https://childrensoncologygroup.org/publications/replication-timing-alterations-in-leukemia-affect-clinically-relevant-chromosome-domains/2026-08-11T04:02:52+00:00https://childrensoncologygroup.org/publications/provocative-questions-in-osteosarcoma-basic-and-translational-biology-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:52+00:00https://childrensoncologygroup.org/publications/childrens-oncology-group-blueprint-for-research-acute-lymphoblastic-leukemia/2026-08-11T04:02:24+00:00https://childrensoncologygroup.org/publications/no-evidence-that-g6pd-deficiency-affects-the-efficacy-or-safety-of-daunorubicin-in-acute-lymphoblastic-leukemia-induction-therapy/2026-08-11T04:02:54+00:00https://childrensoncologygroup.org/publications/treatment-of-childhood-nasopharyngeal-carcinoma-with-induction-chemotherapy-and-concurrent-chemoradiotherapy-results-of-the-childrens-oncology-group-arar0331-study/2026-08-11T04:02:51+00:00https://childrensoncologygroup.org/publications/treatment-of-pediatric-adrenocortical-carcinoma-with-surgery-retroperitoneal-lymph-node-dissection-and-chemotherapy-the-childrens-oncology-group-arar0332-protocol/2026-08-11T04:02:41+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-rare-tumors/2026-08-11T04:02:24+00:00https://childrensoncologygroup.org/publications/persistence-of-chemotherapy-induced-peripheral-neuropathy-despite-vincristine-reduction-in-childhood-b-acute-lymphoblastic-leukemia/2026-08-11T04:02:34+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-germ-cell-tumors/2026-08-11T04:02:24+00:00https://childrensoncologygroup.org/publications/surgical-management-of-paratesticular-rhabdomyosarcoma-a-consensus-opinion-from-the-childrens-oncology-group-european-paediatric-soft-tissue-sarcoma-study-group-and-the-cooperative-weichteilsarkom/2026-08-11T04:02:43+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-cellular-therapy-and-stem-cell-transplantation/2026-08-11T04:02:24+00:00https://childrensoncologygroup.org/publications/patterns-of-national-cancer-institute-sponsored-clinical-trial-enrollment-in-black-adolescents-and-young-adults/2026-08-11T04:02:39+00:00https://childrensoncologygroup.org/publications/the-childrens-oncology-group-adolescent-and-young-adult-responsible-investigator-network-a-new-model-for-addressing-site-level-factors-impacting-clinical-trial-enrollment/2026-08-11T04:02:47+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-renal-tumors/2026-08-11T04:02:24+00:00https://childrensoncologygroup.org/publications/impact-of-local-control-and-surgical-lymph-node-evaluation-in-localized-paratesticular-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group-soft-tissue-sarcoma-committee/2026-08-11T04:02:45+00:00https://childrensoncologygroup.org/publications/rising-drug-cost-impacts-on-cost-effectiveness-of-2-chemotherapy-regimens-for-intermediate-risk-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/impact-of-intrathecal-triple-therapy-versus-intrathecal-methotrexate-on-disease-free-survival-for-high-risk-b-lymphoblastic-leukemia-childrens-oncology-group-study-aall1131/2026-08-11T04:02:47+00:00https://childrensoncologygroup.org/publications/imaging-characteristics-of-nephrogenic-rests-versus-small-wilms-tumors-a-report-from-the-childrens-oncology-group-study-aren03b2/2026-08-11T04:02:49+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-behavioral-science/2026-08-11T04:02:24+00:00https://childrensoncologygroup.org/publications/childrens-oncology-group-2023-blueprint-nursing-discipline/2026-08-11T04:02:24+00:00https://childrensoncologygroup.org/publications/childrens-oncology-group-2023-blueprint-for-research-cancer-care-delivery-research/2026-08-11T04:02:24+00:00https://childrensoncologygroup.org/publications/monitoring-neurocognitive-functioning-after-pediatric-cellular-therapy-or-hematopoietic-cell-transplant-guidelines-from-the-cog-neurocognition-in-cellular-therapies-task-force/2026-08-11T04:02:33+00:00https://childrensoncologygroup.org/publications/imaging-of-pediatric-liver-tumors-a-cog-diagnostic-imaging-committee-spr-oncology-committee-white-paper/2026-08-11T04:02:29+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-pharmacy/2026-08-11T04:02:25+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-neuroblastoma/2026-08-11T04:02:25+00:00https://childrensoncologygroup.org/publications/social-attainment-in-survivors-of-pediatric-central-nervous-system-tumors-a-systematic-review-and-meta-analysis-from-the-childrens-oncology-group/2026-08-11T04:02:51+00:00https://childrensoncologygroup.org/publications/pain-in-long-term-survivors-of-childhood-cancer-a-systematic-review-of-the-current-state-of-knowledge-and-a-call-to-action-from-the-childrens-oncology-group/2026-08-11T04:02:45+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-soft-tissue-sarcomas/2026-08-11T04:02:25+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-epidemiology/2026-08-11T04:02:25+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-non-hodgkin-lymphoma/2026-08-11T04:02:25+00:00https://childrensoncologygroup.org/publications/the-prognostic-significance-of-anaplasia-in-childhood-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:45+00:00https://childrensoncologygroup.org/publications/genomic-classification-and-clinical-outcome-in-rhabdomyosarcoma-a-report-from-an-international-consortium/2026-08-11T04:02:40+00:00https://childrensoncologygroup.org/publications/adverse-prognostic-impact-of-the-loss-of-stag2-protein-expression-in-patients-with-newly-diagnosed-localised-ewing-sarcoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:33+00:00https://childrensoncologygroup.org/publications/antitumor-activity-and-tolerability-of-hu14-18-il2-with-gmcsf-and-isotretinoin-in-recurrent-or-refractory-neuroblastoma-a-childrens-oncology-group-phase-ii-study/2026-08-11T04:02:53+00:00https://childrensoncologygroup.org/publications/comparing-barriers-and-facilitators-to-adolescent-and-young-adult-clinical-trial-enrollment-across-high-and-low-enrolling-community-based-clinics/2026-08-11T04:02:36+00:00https://childrensoncologygroup.org/publications/childrens-oncology-group-2023-blueprint-for-research-adolescent-and-young-adult-oncology/2026-08-11T04:02:25+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-young-investigators/2026-08-11T04:02:25+00:00https://childrensoncologygroup.org/publications/association-of-gstm1-null-variant-with-anthracycline-related-cardiomyopathy-after-childhood-cancer-a-childrens-oncology-group-alte03n1-report/2026-08-11T04:02:47+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research/2026-08-11T04:02:25+00:00https://childrensoncologygroup.org/publications/clinicopathologic-predictors-of-outcomes-in-children-with-stage-i-testicular-germ-cell-tumors-a-pooled-post-hoc-analysis-of-trials-from-the-childrens-oncology-group/2026-08-11T04:02:34+00:00https://childrensoncologygroup.org/publications/perspectives-of-childhood-cancer-symptom-related-distress-results-of-the-state-of-the-science-survey/2026-08-11T04:02:54+00:00https://childrensoncologygroup.org/publications/toxicity-and-pharmacokinetics-of-actinomycin-d-and-vincristine-in-children-and-adolescents-childrens-oncology-group-study-advl06b1/2026-08-11T04:02:41+00:00https://childrensoncologygroup.org/publications/comprehensive-transcriptome-profiling-of-cryptic-cbfa2t3-glis2-fusion-positive-aml-defines-novel-therapeutic-options-a-cog-and-target-pediatric-aml-study/2026-08-11T04:02:50+00:00https://childrensoncologygroup.org/publications/physician-risk-perceptions-and-surveillance-practices-for-tyrosine-kinase-inhibitor-long-term-effects-in-pediatric-cml/2026-08-11T04:02:35+00:00https://childrensoncologygroup.org/publications/age-diagnostic-category-tumor-grade-and-mitosis-karyorrhexis-index-are-independently-prognostic-in-neuroblastoma-an-inrg-project/2026-08-11T04:02:48+00:00https://childrensoncologygroup.org/publications/clinical-features-and-outcomes-of-young-patients-with-epithelioid-sarcoma-an-analysis-from-the-childrens-oncology-group-and-the-european-paediatric-soft-tissue-sarcoma-study-group-prospective-clinic/2026-08-11T04:02:55+00:00https://childrensoncologygroup.org/publications/a-risk-based-treatment-strategy-for-non-rhabdomyosarcoma-soft-tissue-sarcomas-in-patients-younger-than-30-years-arst0332-a-childrens-oncology-group-prospective-study/2026-08-11T04:02:51+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-cancer-control-and-supportive-care/2026-08-11T04:02:25+00:00https://childrensoncologygroup.org/publications/childrens-oncology-groups-2023-blueprint-for-research-developmental-therapeutics/2026-08-11T04:02:25+00:00https://childrensoncologygroup.org/publications/il-10-and-tnf%ce%b1-are-associated-with-decreased-survival-in-low-risk-pediatric-acute-myeloid-leukemia-a-childrens-oncology-group-report/2026-08-11T04:02:31+00:00https://childrensoncologygroup.org/publications/identification-and-targeting-of-treatment-resistant-progenitor-populations-in-t-cell-acute-lymphoblastic-leukemia/2026-08-11T04:02:22+00:00https://childrensoncologygroup.org/publications/phase-i-ii-trial-of-vorinostat-and-radiation-and-maintenance-vorinostat-in-children-with-diffuse-intrinsic-pontine-glioma-a-childrens-oncology-group-report/2026-08-11T04:02:37+00:00https://childrensoncologygroup.org/publications/facilitators-and-barriers-to-clinical-practice-guideline-consistent-supportive-care-at-pediatric-oncology-institutions-a-childrens-oncology-group-study/2026-08-11T04:02:40+00:00https://childrensoncologygroup.org/publications/the-covid-19-pandemic-a-rapid-global-response-for-children-with-cancer-from-siop-cog-siop-e-siop-podc-ipso-pros-cci-and-st-jude-global/2026-08-11T04:02:48+00:00https://childrensoncologygroup.org/publications/haplotype-resolved-germline-and-somatic-alterations-in-renal-medullary-carcinomas/2026-08-11T04:02:41+00:00https://childrensoncologygroup.org/publications/biologic-and-clinical-features-of-childhood-gamma-delta-t-all-identification-of-stag2-lmo2-%ce%b3%ce%b4-t-all-as-an-extremely-high-risk-leukemia-in-the-very-young/2026-08-11T04:02:21+00:00https://childrensoncologygroup.org/publications/prognostic-impact-of-csf3r-mutations-in-favorable-risk-childhood-acute-myeloid-leukemia/2026-08-11T04:02:49+00:00https://childrensoncologygroup.org/publications/functional-properties-of-kit-mutations-are-associated-with-differential-clinical-outcomes-and-response-to-targeted-therapeutics-in-cbf-acute-myeloid-leukemia/2026-08-11T04:02:53+00:00https://childrensoncologygroup.org/publications/cebpa-bzip-mutations-are-associated-with-favorable-prognosis-in-de-novo-aml-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:40+00:00https://childrensoncologygroup.org/publications/childrens-oncology-group-trial-aall1231-a-phase-iii-clinical-trial-testing-bortezomib-in-newly-diagnosed-t-cell-acute-lymphoblastic-leukemia-and-lymphoma/2026-08-11T04:02:35+00:00https://childrensoncologygroup.org/publications/optimizing-therapy-in-the-modern-age-differences-in-length-of-maintenance-therapy-in-acute-lymphoblastic-leukemia/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/how-i-treat-newly-diagnosed-t-cell-acute-lymphoblastic-leukemia-and-t-cell-lymphoblastic-lymphoma-in-children/2026-08-11T04:02:51+00:00https://childrensoncologygroup.org/publications/you-cannot-diagnose-what-you-cannot-see-the-importance-of-optimized-imaging-protocols-for-accurate-disease-staging-and-assessment/2026-08-11T04:02:23+00:00https://childrensoncologygroup.org/publications/international-consensus-classification-of-acute-lymphoblastic-leukemia-lymphoma/2026-08-11T04:02:32+00:00https://childrensoncologygroup.org/publications/abl-class-fusion-positive-acute-lymphoblastic-leukemia-can-targeting-abl-cure-all/2026-08-11T04:02:48+00:00https://childrensoncologygroup.org/publications/the-ebf1-pdgfrb-t681i-mutation-is-highly-resistant-to-imatinib-and-dasatinib-in-vitro-and-detectable-in-clinical-samples-prior-to-treatment/2026-08-11T04:02:41+00:00https://childrensoncologygroup.org/publications/clinical-and-biological-features-prognostic-of-survival-after-relapse-or-progression-of-inrgss-stage-ms-pattern-neuroblastoma-a-report-from-the-international-neuroblastoma-risk-group-inrg-project/2026-08-11T04:02:32+00:00https://childrensoncologygroup.org/publications/small-cell-undifferentiated-histology-does-not-adversely-affect-outcome-in-hepatoblastoma-a-report-from-the-childrens-oncology-group-cog-ahep0731-study-committee/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/maintaining-outstanding-outcomes-using-response-and-biology-based-therapy-for-intermediate-risk-neuroblastoma-a-report-from-the-childrens-oncology-group-study-anbl0531/2026-08-11T04:02:51+00:00https://childrensoncologygroup.org/publications/integrated-genomic-analysis-identifies-ubtf-tandem-duplications-as-a-recurrent-lesion-in-pediatric-acute-myeloid-leukemia/2026-08-11T04:02:36+00:00https://childrensoncologygroup.org/publications/bortezomib-is-significantly-beneficial-for-de-novo-pediatric-aml-patients-with-low-phosphorylation-of-the-nf-%ce%bab-subunit-rela/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/identification-of-tcf3-germline-variants-in-pediatric-b-cell-acute-lymphoblastic-leukemia/2026-08-11T04:02:30+00:00https://childrensoncologygroup.org/publications/the-childhood-cancer-data-initiative-using-the-power-of-data-to-learn-from-and-improve-outcomes-for-every-child-and-young-adult-with-pediatric-cancer/2026-08-11T04:02:25+00:00https://childrensoncologygroup.org/publications/outcomes-of-children-with-well-differentiated-fetal-hepatoblastoma-treated-with-surgery-only-report-from-childrens-oncology-group-trial-ahep0731/2026-08-11T04:02:33+00:00https://childrensoncologygroup.org/publications/synovial-sarcoma-in-children-adolescents-and-young-adults-a-report-from-the-childrens-oncology-group-arst0332-study/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/identification-of-four-novel-associations-for-b-cell-acute-lymphoblastic-leukaemia-risk/2026-08-11T04:02:51+00:00https://childrensoncologygroup.org/publications/pattern-and-predictors-of-sites-of-relapse-in-neuroblastoma-a-report-from-the-international-neuroblastoma-risk-group-inrg-project/2026-08-11T04:02:34+00:00https://childrensoncologygroup.org/publications/precision-medicine-in-pediatric-oncology/2026-08-11T04:02:51+00:00https://childrensoncologygroup.org/publications/comparison-of-design-methods-for-a-safety-run-in-phase-of-a-phase-ii-clinical-trial/2026-08-11T04:02:31+00:00https://childrensoncologygroup.org/publications/etiology-of-oncogenic-fusions-in-5190-childhood-cancers-and-its-clinical-and-therapeutic-implication/2026-08-11T04:02:30+00:00https://childrensoncologygroup.org/publications/design-and-methods-of-a-randomized-web-based-physical-activity-intervention-among-children-with-cancer-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:33+00:00https://childrensoncologygroup.org/publications/national-cancer-institute-combination-therapy-platform-trial-with-molecular-analysis-for-therapy-choice-combomatch/2026-08-11T04:02:30+00:00https://childrensoncologygroup.org/publications/automated-quantification-of-baseline-imaging-pet-metrics-on-fdg-pet-ct-images-of-pediatric-hodgkin-lymphoma-patients/2026-08-11T04:02:45+00:00https://childrensoncologygroup.org/publications/pathological-response-in-children-and-adults-with-large-unresected-intermediate-grade-or-high-grade-soft-tissue-sarcoma-receiving-preoperative-chemoradiotherapy-with-or-without-pazopanib-arst1321-a/2026-08-11T04:02:47+00:00https://childrensoncologygroup.org/publications/characteristics-and-prognostic-impact-of-idh-mutations-in-aml-a-cog-swog-and-ecog-analysis/2026-08-11T04:02:22+00:00https://childrensoncologygroup.org/publications/a-safety-and-feasibility-trial-of-131-i-mibg-in-newly-diagnosed-high-risk-neuroblastoma-a-childrens-oncology-group-study/2026-08-11T04:02:40+00:00https://childrensoncologygroup.org/publications/evaluation-of-the-diagnostic-biopsy-approach-for-children-with-hepatoblastoma-a-report-from-the-childrens-oncology-group-ahep-0731-liver-tumor-committee/2026-08-11T04:02:49+00:00https://childrensoncologygroup.org/publications/persistence-of-racial-and-ethnic-disparities-in-risk-and-survival-for-patients-with-neuroblastoma-over-two-decades/2026-08-11T04:02:21+00:00https://childrensoncologygroup.org/publications/outcome-for-children-and-young-adults-with-t-cell-all-and-induction-failure-in-contemporary-trials/2026-08-11T04:02:21+00:00https://childrensoncologygroup.org/publications/congenital-spindle-cell-rhabdomyosarcoma-an-international-cooperative-analysis/2026-08-11T04:02:36+00:00https://childrensoncologygroup.org/publications/charting-a-path-for-prioritization-of-novel-agents-for-clinical-trials-in-osteosarcoma-a-report-from-the-childrens-oncology-group-new-agents-for-osteosarcoma-task-force/2026-08-11T04:02:40+00:00https://childrensoncologygroup.org/publications/associations-between-birth-defects-and-childhood-and-adolescent-germ-cell-tumors-according-to-sex-histologic-subtype-and-site/2026-08-11T04:02:22+00:00https://childrensoncologygroup.org/publications/randomized-assessment-of-delayed-intensification-and-two-methods-for-parenteral-methotrexate-delivery-in-childhood-b-all-childrens-oncology-group-studies-p9904-and-p9905/2026-08-11T04:02:49+00:00https://childrensoncologygroup.org/publications/vpreb-surrogate-light-chain-expression-in-b-lineage-all-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/information-fraction-estimation-strategies-for-a-phase-3-non-inferiority-maximum-duration-design-with-time-to-event-outcome/2026-08-11T04:02:22+00:00https://childrensoncologygroup.org/publications/commonly-reported-adverse-events-associated-with-pediatric-immunotherapy-a-systematic-review-from-the-childrens-oncology-group/2026-08-11T04:02:45+00:00https://childrensoncologygroup.org/publications/advances-in-the-clinical-management-of-high-risk-wilms-tumors/2026-08-11T04:02:30+00:00https://childrensoncologygroup.org/publications/creating-a-data-commons-the-international-soft-tissue-sarcoma-consortium-instruct/2026-08-11T04:02:33+00:00https://childrensoncologygroup.org/publications/genetic-and-epigenetic-features-of-bilateral-wilms-tumor-predisposition-in-patients-from-the-childrens-oncology-group-aren18b5-q/2026-08-11T04:02:20+00:00https://childrensoncologygroup.org/publications/genomic-and-clinical-characterization-of-early-t-cell-precursor-lymphoblastic-lymphoma/2026-08-11T04:02:41+00:00https://childrensoncologygroup.org/publications/adherence-to-surveillance-for-second-malignant-neoplasms-and-cardiac-dysfunction-in-childhood-cancer-survivors-a-childhood-cancer-survivor-study/2026-08-11T04:02:48+00:00https://childrensoncologygroup.org/publications/outcomes-of-childhood-noninfant-acute-lymphoblastic-leukemia-with-11q23-kmt2a-rearrangements-in-a-modern-therapy-era-a-retrospective-international-study/2026-08-11T04:02:31+00:00https://childrensoncologygroup.org/publications/genetics-of-osteonecrosis-in-pediatric-acute-lymphoblastic-leukemia-and-general-populations/2026-08-11T04:02:43+00:00https://childrensoncologygroup.org/publications/association-of-inherited-genetic-factors-with-drug-induced-hepatic-damage-among-children-with-acute-lymphoblastic-leukemia/2026-08-11T04:02:33+00:00https://childrensoncologygroup.org/publications/long-term-follow-up-of-a-phase-iii-study-of-ch14-18-dinutuximab-cytokine-immunotherapy-in-children-with-high-risk-neuroblastoma-cog-study-anbl0032/2026-08-11T04:02:43+00:00https://childrensoncologygroup.org/publications/germline-genetic-nbn-variation-and-predisposition-to-b-cell-acute-lymphoblastic-leukemia-in-children/2026-08-11T04:02:26+00:00https://childrensoncologygroup.org/publications/mycn-amplification-and-atrx-mutations-are-incompatible-in-neuroblastoma/2026-08-11T04:02:50+00:00https://childrensoncologygroup.org/publications/chlorhexidine-gluconate-bathing-in-children-with-cancer-or-those-undergoing-hematopoietic-stem-cell-transplantation-a-double-blinded-randomized-controlled-trial-from-the-childrens-oncology-group/2026-08-11T04:02:45+00:00https://childrensoncologygroup.org/publications/association-of-gata3-polymorphisms-with-minimal-residual-disease-and-relapse-risk-in-childhood-acute-lymphoblastic-leukemia/2026-08-11T04:02:43+00:00https://childrensoncologygroup.org/publications/deep-learning-of-rhabdomyosarcoma-pathology-images-for-classification-and-survival-outcome-prediction/2026-08-11T04:02:36+00:00https://childrensoncologygroup.org/publications/epigenome-wide-association-study-reveals-cpg-sites-related-to-cog-of-neuroblastoma/2026-08-11T04:02:48+00:00https://childrensoncologygroup.org/publications/population-pharmacokinetics-and-exposure-safety-relationships-of-alisertib-in-children-and-adolescents-with-advanced-malignancies/2026-08-11T04:02:38+00:00https://childrensoncologygroup.org/publications/prognostic-and-therapeutic-utility-of-variably-expressed-cell-surface-receptors-in-osteosarcoma/2026-08-11T04:02:44+00:00https://childrensoncologygroup.org/publications/outcome-of-children-with-intermediate-risk-extracranial-malignant-germ-cell-tumors-by-response-status-at-the-end-of-induction-chemotherapy-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:07+00:00https://childrensoncologygroup.org/publications/subsequent-neoplasm-risk-after-modern-mediastinal-radiation-therapy-for-pediatric-hodgkin-lymphoma-insights-from-a-multi-institutional-childrens-oncology-group-trial/2026-08-11T04:02:06+00:00https://childrensoncologygroup.org/publications/comparisons-between-individual-and-area-level-measures-of-socioeconomic-status-among-childhood-cancer-patients-a-report-from-the-childrens-oncology-group-cog/2026-08-11T04:02:05+00:00https://childrensoncologygroup.org/publications/fda-approvals-for-pediatric-cancer-indications-using-childrens-oncology-group-associated-trials-data/2026-08-11T04:02:05+00:00https://childrensoncologygroup.org/publications/atezolizumab-plus-folfox-for-stage-iii-mismatch-repair-deficient-colon-cancer/2026-08-11T04:02:05+00:00https://childrensoncologygroup.org/publications/autoimmune-lymphoproliferative-immunodeficiencies-alpids-a-proposed-approach-to-redefining-alps-and-other-lymphoproliferative-immune-disorders/2026-08-11T04:02:20+00:00https://childrensoncologygroup.org/publications/phase-1-2-trial-of-talazoparib-in-combination-with-temozolomide-in-children-and-adolescents-with-refractory-recurrent-solid-tumors-including-ewing-sarcoma-a-childrens-oncology-group-phase-1-consorti/2026-08-11T04:02:50+00:00https://childrensoncologygroup.org/publications/nivolumab-in-children-and-young-adults-with-relapsed-refractory-solid-tumors-advl1412-a-phase-1-2-trial/2026-08-11T04:02:49+00:00https://childrensoncologygroup.org/publications/phase-i-clinical-trial-of-the-wee1-inhibitor-adavosertib-azd1775-with-irinotecan-in-children-with-relapsed-solid-tumors-a-cog-phase-1-consortium-report-advl1312/2026-08-11T04:02:50+00:00https://childrensoncologygroup.org/publications/safety-tolerability-and-pharmacokinetics-of-crizotinib-in-combination-with-cytotoxic-chemotherapy-for-pediatric-patients-with-refractory-solid-tumors-or-anaplastic-large-cell-lymphoma-alcl-a-child/2026-08-11T04:02:45+00:00https://childrensoncologygroup.org/publications/a-phase-1-study-of-entinostat-in-children-and-adolescents-with-recurrent-or-refractory-solid-tumors-including-cns-tumors-trial-advl1513-pediatric-early-phase-clinical-trial-network-pep-ctn/2026-08-11T04:02:43+00:00https://childrensoncologygroup.org/publications/a-phase-1-study-of-prexasertib-ly2606368-a-chk1-2-inhibitor-in-pediatric-patients-with-recurrent-or-refractory-solid-tumors-including-cns-tumors-a-report-from-the-childrens-oncology-group-pedia/2026-08-11T04:02:40+00:00https://childrensoncologygroup.org/publications/activity-of-crizotinib-in-patients-with-alk-aberrant-relapsed-refractory-neuroblastoma-a-childrens-oncology-group-study-advl0912/2026-08-11T04:02:42+00:00https://childrensoncologygroup.org/publications/wee1-kinase-inhibitor-adavosertib-with-radiation-in-newly-diagnosed-diffuse-intrinsic-pontine-glioma-a-childrens-oncology-group-phase-i-consortium-study/2026-08-11T04:02:36+00:00https://childrensoncologygroup.org/publications/pediatric-phase-2-trial-of-a-wee1-inhibitor-adavosertib-azd1775-and-irinotecan-for-relapsed-neuroblastoma-medulloblastoma-and-rhabdomyosarcoma/2026-08-11T04:02:26+00:00https://childrensoncologygroup.org/publications/a-phase-i-ii-trial-of-nivolumab-plus-ipilimumab-in-children-and-young-adults-with-relapsed-refractory-solid-tumors-a-childrens-oncology-group-study-advl1412/2026-08-11T04:02:33+00:00https://childrensoncologygroup.org/publications/a-phase-2-study-of-pepinemab-in-children-adolescents-or-young-adults-with-recurrent-or-refractory-solid-tumors-a-childrens-oncology-group-consortium-report-advl1614/2026-08-11T04:02:18+00:00https://childrensoncologygroup.org/publications/a-phase-1-study-of-abi%e2%80%90009-nab%e2%80%90sirolimus-in-combination-with-temozolomide-and-irinotecan-in-pediatric-patients-with-recurrent-or-refractory-solid-tumors-including-cns-tumors/2026-08-11T04:02:14+00:00https://childrensoncologygroup.org/publications/incorporating-intensity-modulated-total-body-irradiation-imrt-tbi-into-future-cooperative-group-clinical-trials-an-nrg-hematologic-malignancies-working-group-led-report-from-the-national-clinical-t/2026-08-11T04:02:06+00:00https://childrensoncologygroup.org/publications/alveolar-soft-part-sarcoma-in-pediatric-and-young-adult-patients-a-report-from-the-childrens-oncology-group-study-arst0332/2026-08-11T04:02:05+00:00https://childrensoncologygroup.org/publications/three-year-follow-up-of-nivolumab-avd-versus-brentuximab-vedotin-avd-in-adolescents-with-advanced-stage-classic-hodgkin-lymphoma-on-s1826/2026-08-11T04:02:06+00:00https://childrensoncologygroup.org/publications/outcomes-following-radiotherapy-for-atypical-teratoid-rhabdoid-tumor-in-combination-with-surgery-and-intensive-chemotherapy-a-report-from-childrens-oncology-group-study-acns0333/2026-08-11T04:02:07+00:00https://childrensoncologygroup.org/publications/pepn1924-a-phase-ii-study-of-trastuzumab-deruxtecan-in-patients-with-recurrent-human-epidermal-growth-factor-receptor-2-osteosarcoma-a-childrens-oncology-group-pediatric-early-phase-clinical-trial/2026-08-11T04:02:08+00:00https://childrensoncologygroup.org/publications/standard-dose-versus-high-dose-cisplatin-for-intermediate-poor-risk-extracranial-malignant-germ-cell-tumors-re-analysis-of-pediatric-oncology-group-9049-and-childrens-cancer-group-8882-trial-using-u/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/nonorbital-nonparameningeal-head-and-neck-rhabdomyosarcoma-a-report-from-the-childrens-oncology-group-pediatr-blood-cancer/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/childhood-body-mass-index-at-diagnosis-and-its-association-with-non-hodgkin-lymphoma-in-the-united-states-a-childrens-oncology-group-data-analysis-project/2026-08-11T04:02:10+00:00https://childrensoncologygroup.org/publications/hematopoietic-stem-cell-transplantation-does-not-improve-the-poor-outcome-of-children-with-hypodiploid-acute-lymphoblastic-leukemia-a-report-from-childrens-oncology-group/2026-08-11T04:02:55+00:00https://childrensoncologygroup.org/publications/correction-detection-of-circulating-tumour-dna-is-associated-with-inferior-outcomes-in-ewing-sarcoma-and-osteosarcoma-a-report-from-the-childrens-oncology-group/2026-08-11T04:02:55+00:00https://childrensoncologygroup.org/publications/conformal-radiation-therapy-for-pediatric-patients-with-low-grade-glioma-results-from-the-childrens-oncology-group-phase-2-study-acns0221/2026-08-11T04:02:55+00:00https://childrensoncologygroup.org/publications/publisher-correction-the-molecular-landscape-of-pediatric-acute-myeloid-leukemia-reveals-recurrent-structural-alterations-and-age-specific-mutational-interactions/2026-08-11T04:02:55+00:00https://childrensoncologygroup.org/publications/outcome-for-pediatric-acute-promyelocytic-leukemia-patients-at-childrens-oncology-group-sites-on-the-leukemia-intergroup-study-calgb-9710-alliance/2026-08-11T04:02:55+00:00https://childrensoncologygroup.org/publications/survival-and-prognosis-with-osteosarcoma-outcomes-in-more-than-2000-patients-in-the-euramos-1-european-and-american-osteosarcoma-study-cohort/2026-08-11T04:02:55+00:00https://childrensoncologygroup.org/publications/targeting-eif4e-signaling-with-ribavirin-in-infant-acute-lymphoblastic-leukemia/2026-08-11T04:02:56+00:00https://childrensoncologygroup.org/publications/bayesian-adaptive-enrichment-design-for-continuous-biomarkers/2026-08-11T04:02:56+00:00https://childrensoncologygroup.org/publications/late-effects-after-high-risk-neuroblastoma-leahrn-a-multicentre-cross-sectional-cohort-study-from-the-childrens-oncology-group/2026-08-11T04:02:56+00:00https://childrensoncologygroup.org/publications/multimodality-artificial-intelligence-for-involved-site-radiation-therapy-clinical-target-volume-delineation-in-high-risk-pediatric-hodgkin-lymphoma/2026-08-11T04:02:56+00:00https://childrensoncologygroup.org/publications/enhancing-radiation-therapy-quality-assurance-in-lymphoma-a-rigorous-real-time-central-review-process-in-ahod2131/2026-08-11T04:02:56+00:00https://childrensoncologygroup.org/publications/frequency-and-face-validity-of-reported-family-history-of-cancer-in-first-degree-relatives-and-genetic-syndromes-among-children-with-cancer-in-projecteverychild-a-report-from-the-childrens-oncology/2026-08-11T04:02:56+00:00https://childrensoncologygroup.org/publications/cumulative-dose-of-chemotherapy-and-survival-outcomes-in-children-with-average-risk-medulloblastoma-treated-on-childrens-oncology-group-study-acns0331/2026-08-11T04:02:56+00:00https://childrensoncologygroup.org/publications/consensus-radiation-therapy-organ-at-risk-constraints-for-nctn-trials-in-hematologic-malignancies/2026-08-11T04:02:56+00:00